RESULT_COUNT: 410,PAGE_SIZE: 10000,CURRENT_PAGE: 1,TOTAL_PAGES: 1,API_CALL_CREDITS: 1
TICKER,FIGI_TICKER,FIGI,TITLE,PUBLICATION_DATE,URL,SUMMARY
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company to Announce Third-Quarter 2017 Financial Results on October 25,2017-10-20 11:00:00 +0000,https://finance.yahoo.com/news/medicines-company-announce-third-quarter-110000707.html?.tsrc=rss,"The Medicines Company  will host a conference call on Wednesday, October 25, 2017, at 8:30 a.m., Eastern Time, to discuss its third-quarter 2017 financial results and operational developments."
MDCO,MDCO:UW,BBG000DX6TV8,Vabomere: Major Addition to The Medicines Company’s Portfolio?,2017-10-17 14:38:57 +0000,http://finance.yahoo.com/r/4d1f5d93-048d-31e6-8368-a3a92d08f7d0/vabomere-may-prove-major-addition-medicines-companys-portfolio-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"On August 29, 2017, the FDA approved The Medicines Company’s (MDCO) Vabomere for treating adulating patients suffering with complicated urinary tract infections."
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company May See Improvement in Payer Access,2017-10-17 13:10:30 +0000,http://finance.yahoo.com/r/d3eeaf99-0d17-3ea1-99f3-f32d77f06e6f/medicines-company-may-witness-improvement-payer-access-pcsk9-inhibitors-future-years?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"On August 28, 2017, The Medicines Company (MDCO) announced positive data from its Phase 2 trial, ORION-1, evaluating the efficacy of PCSK9 synthesis inhibitor inclisiran."
MDCO,MDCO:UW,BBG000DX6TV8,Inclisiran: Long-Term Growth Driver for The Medicines Company?,2017-10-17 12:37:54 +0000,http://finance.yahoo.com/r/53925e6d-2167-3a10-ad3c-fd3e291b3871/inclisiran-may-prove-major-long-term-growth-driver-medicines-company?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"According to a Monte Carlo simulation performed at Harvard, it's estimated that 5.0 million patients in the United States stand to benefit from PCSK9 inhibitor therapy."
MDCO,MDCO:UW,BBG000DX6TV8,Corbus Pharmaceuticals Appoints Paris Panayiotopoulos to Its Board of Directors,2017-10-17 11:30:00 +0000,https://finance.yahoo.com/news/corbus-pharmaceuticals-appoints-paris-panayiotopoulos-113000216.html?.tsrc=rss,"Corbus Pharmaceuticals Holdings, Inc. , a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, announced today that it has appointed Mr. Paris......"
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company May Report Steep Revenue Decline in 2017,2017-10-16 21:05:58 +0000,http://finance.yahoo.com/r/169a9fc9-11b3-37ef-9da4-2d8ea5216b6e/medicines-company-may-report-steep-decline-revenues-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2Q17, The Medicines Company (MDCO) reported a net loss from continuing operations of $397.3 million, which was a significant fall from $181.8 million in 2Q16."
MDCO,MDCO:UW,BBG000DX6TV8,Analysts’ Recommendations for The Medicines Company in October,2017-10-16 19:10:58 +0000,http://finance.yahoo.com/r/783cdc1c-fd50-3dcd-a9bf-72857dd049ff/analysts-recommendations-medicines-company-peers-october-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2Q17, The Medicines Company (MDCO) reported revenues of $18.7 million, which is a fall of 66.0% on a YoY (year-over-year) basis."
MDCO,MDCO:UW,BBG000DX6TV8,"The Medicines Co. – Value Analysis (NASDAQ:MDCO) : October 13, 2017",2017-10-13 15:40:51 +0000,http://finance.yahoo.com/r/8381777b-b5ba-30f5-bd41-e7b534198879/the-medicines-co-value-analysis-nasdaqmdco-october-13-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives The Medicines Co. a score of 16. Our analysis is based on comparing The Medicines Co. with the following peers – Innoviva, Inc., Eagle Pharmaceuticals, Inc., Vericel Corporation, Pfizer Inc., Teva Pharmaceutical Industries Limited Sponsored ADR, Momenta Pharmaceuticals, Inc., Astrazeneca PLC Sponsored ADR, Johnson & Johnson, Bristol-Myers ... Read more
<b>(Read more...)</b>"
MDCO,MDCO:UW,BBG000DX6TV8,"The Medicines Co. breached its 50 day moving average in a Bearish Manner : MDCO-US : October 12, 2017",2017-10-12 12:25:42 +0000,http://finance.yahoo.com/r/96790767-c3ff-33b8-b4a8-6fa75cba0bd8/the-medicines-co-breached-its-50-day-moving-average-in-a-bearish-manner-mdco-us-october-12-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for The Medicines Co.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish ... Read more
<b>(Read more...)</b>"
MDCO,MDCO:UW,BBG000DX6TV8,Should You Have The Medicines Company’s (MDCO) In Your Portfolio?,2017-10-05 12:06:13 +0000,https://finance.yahoo.com/news/medicines-company-mdco-portfolio-120613051.html?.tsrc=rss,"If you are a shareholder in The Medicines Company’s (NASDAQ:MDCO), or are thinking about investing in the company, knowing how it contributes to the risk and reward profile of yourRead More..."
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company to Present New Data from TANGO II Study of VABOMERE™ (meropenem and vaborbactam) at IDWeek 2017,2017-10-05 11:00:00 +0000,https://finance.yahoo.com/news/medicines-company-present-data-tango-110000436.html?.tsrc=rss,The Medicines Company today announced that new data from its TANGO II study of VABOMERE will be presented this week at IDWeek 2017 in San Diego.
MDCO,MDCO:UW,BBG000DX6TV8,"ETFs with exposure to The Medicines Co. : October 4, 2017",2017-10-04 14:50:46 +0000,http://finance.yahoo.com/r/2bb7e4f1-3417-3c27-ba14-dae2e87accfe/etfs-with-exposure-to-the-medicines-co-october-4-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to The Medicines Co. Here are 5 ETFs with the largest exposure to MDCO-US. Comparing the performance and risk of The Medicines Co. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
MDCO,MDCO:UW,BBG000DX6TV8,See what the IHS Markit Score report has to say about Medicines Co.,2017-10-02 12:06:35 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120635680.html?.tsrc=rss,Medicines Co NASDAQ/NGS:MDCO
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company to Present Data at IDWeek 2017 on Infectious Disease Portfolio Including Recently Approved Antibiotic VABOMERE™ (meropenem and vaborbactam),2017-09-28 20:30:00 +0000,https://finance.yahoo.com/news/medicines-company-present-data-idweek-203000557.html?.tsrc=rss,"The Medicines Company  today announced that data from its portfolio of antimicrobial products will be featured in presentations at IDWeek 2017 to be held October 4-8, 2017 in San Diego."
MDCO,MDCO:UW,BBG000DX6TV8,"The Medicines Co. breached its 50 day moving average in a Bullish Manner : MDCO-US : September 28, 2017",2017-09-28 12:17:51 +0000,http://finance.yahoo.com/r/9d5f6d8d-39a9-3c88-a71c-926e6f363f86/the-medicines-co-breached-its-50-day-moving-average-in-a-bullish-manner-mdco-us-september-28-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for The Medicines Co.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish ... Read more
<b>(Read more...)</b>"
MDCO,MDCO:UW,BBG000DX6TV8,Gene Therapy: A Big Week for Many Names,2017-09-25 13:57:00 +0000,http://finance.yahoo.com/r/d83c2532-8e77-327e-a958-c7fa98ebcf0a/gene-therapy-a-big-week-for-many-names-1506347828?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"It’s been a big week for the gene therapy universe.  Of course, there’s the latest Barron’s  cover story, which details the emerging medical revolution and highlights three stocks -- AveXis (AVXS), Regenxbio (RGNX), and Spark Therapeutics (ONCE) -- that have big stakes in what is widely considered one of the most exciting areas in the biotechnology arena.  Last week, Ultragenyx Pharmaceutical (RARE) offered to buy  Dimension Therapeutics (DMTX) for at $5.50 per share in cash."
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Co. Continues to Focus on Pipeline Development,2017-09-22 16:35:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yJ7vXYibVuM/the-medicines-co-continues-to-focus-on-pipeline-development-cm849632,We issued an updated report on The Medicines Company MDCO on Sep 21 Notably the Medicines Co has undertaken a restructuring program to boost shareholder value In fact the company is exploring options for optimizing capital structure and liquidity position by divesting certain non
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Co. Continues to Focus on Pipeline Development,2017-09-22 14:41:02 +0000,https://finance.yahoo.com/news/medicines-co-continues-focus-pipeline-144102091.html?.tsrc=rss,The Medicines Co.&apos;s (MDCO) divestment of non-core assets should allow the company to focus on key assets and brings in a non-dilutive source of funds as well.
MDCO,MDCO:UW,BBG000DX6TV8,See what the IHS Markit Score report has to say about Medicines Co.,2017-09-18 12:06:51 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120651906.html?.tsrc=rss,Medicines Co NASDAQ/NGS:MDCO
MDCO,MDCO:UW,BBG000DX6TV8,"ETFs with exposure to The Medicines Co. : September 13, 2017",2017-09-13 22:56:26 +0000,http://finance.yahoo.com/r/1a81f5a6-ae82-346a-a57a-e6e75d5dac06/etfs-with-exposure-to-the-medicines-co-september-13-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to The Medicines Co. Here are 5 ETFs with the largest exposure to MDCO-US. Comparing the performance and risk of The Medicines Co. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
MDCO,MDCO:UW,BBG000DX6TV8,See what the IHS Markit Score report has to say about Medicines Co.,2017-09-12 12:05:43 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120543224.html?.tsrc=rss,Medicines Co NASDAQ/NGS:MDCO
MDCO,MDCO:UW,BBG000DX6TV8,"The Medicines Co. :MDCO-US: Earnings Analysis: Q2, 2017 By the Numbers : September 11, 2017",2017-09-11 17:09:04 +0000,http://finance.yahoo.com/r/7351f409-5800-3a8a-b2be-907fc34e5e56/the-medicines-co-mdco-us-earnings-analysis-q2-2017-by-the-numbers-september-11-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis The Medicines Co. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of The Medicines Co. – Innoviva, Inc., Eagle Pharmaceuticals, Inc., Momenta Pharmaceuticals, Inc., Pfizer Inc., Teva Pharmaceutical Industries Limited Sponsored ADR, Vericel Corporation, Astrazeneca PLC Sponsored ADR, Johnson & ... Read more
<b>(Read more...)</b>"
MDCO,MDCO:UW,BBG000DX6TV8,"The Medicines Co. breached its 50 day moving average in a Bearish Manner : MDCO-US : September 8, 2017",2017-09-08 15:10:19 +0000,http://finance.yahoo.com/r/a58bc6c8-cdfc-3bf5-8d7a-89293390250d/the-medicines-co-breached-its-50-day-moving-average-in-a-bearish-manner-mdco-us-september-8-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for The Medicines Co.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish ... Read more
<b>(Read more...)</b>"
MDCO,MDCO:UW,BBG000DX6TV8,New Drugs Approved In August,2017-09-07 05:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZoP1iaTzo4w/new-drugs-approved-in-august-20170907-00189,New Drugs Approved In August
MDCO,MDCO:UW,BBG000DX6TV8,See what the IHS Markit Score report has to say about Medicines Co.,2017-09-02 12:11:11 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-121111680.html?.tsrc=rss,Medicines Co NASDAQ/NGS:MDCO
MDCO,MDCO:UW,BBG000DX6TV8,Corporate News Blog - FDA Grants Approval to The Medicines Co.’s VABOMERE(TM),2017-09-01 11:20:00 +0000,https://finance.yahoo.com/news/corporate-news-blog-fda-grants-112000717.html?.tsrc=rss,"Research Desk Line-up: SteadyMed Post Earnings Coverage LONDON, UK / ACCESSWIRE / September 1, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for The ..."
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company's Infection Drug Vabomere Gets FDA Nod,2017-08-31 15:56:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9iTy3qrahf4/the-medicines-companys-infection-drug-vabomere-gets-fda-nod-cm839749,The Medicines Company MDCO announced that the FDA has granted accelerated approval to its experimental antibiotic Vabomere a combination of meropenem and vaborbactam for treating complicated urinary tract infections cUTI including the pyelonephritis The company expects to make
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company's Infection Drug Vabomere Gets FDA Nod,2017-08-31 15:56:17 +0000,,The Medicines Company MDCO announced that the FDA has granted accelerated approval to its experimental antibiotic Vabomere a combination of meropenem and vaborbactam for treating complicated urinary tract infections cUTI including the pyelonephritis The company expects to make
MDCO,MDCO:UW,BBG000DX6TV8,"Biotech Stock Roundup: CAR-T in Focus on Gilead-Kite Deal, Incyte Up on Baricitinib Update",2017-08-31 14:55:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Fr6yNe5WHj0/biotech-stock-roundup-car-t-in-focus-on-gilead-kite-deal-incyte-up-on-baricitinib-update-cm839673,CAR T stocks were in the news this week with key biotech player Gilead Sciences GILD announcing its intention to acquire Kite Pharma KITE one of the most advanced players in the CAR T therapy market Moreover the FDA approved Novartis Kymriah yesterday making it the first CAR T therapy
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company&apos;s Infection Drug Vabomere Gets FDA Nod,2017-08-31 13:26:01 +0000,https://finance.yahoo.com/news/medicines-company-apos-infection-drug-132601396.html?.tsrc=rss,The Medicines Company&apos;s (MDCO) infection-resistant antibiotic Vabomere secures a fast FDA approval for urinary tract diseases. The drug is likely to hit the market in fourth-quarter 2017.
MDCO,MDCO:UW,BBG000DX6TV8,"Biotech Stock Roundup: CAR-T in Focus on Gilead-Kite Deal, Incyte Up on Baricitinib Update",2017-08-31 12:42:12 +0000,https://finance.yahoo.com/news/biotech-stock-roundup-car-t-124212645.html?.tsrc=rss,It&apos;s all about CAR-T stocks this week with Gilead (GILD) announcing its intention to acquire Kite Pharma for $11.9 billion and Novartis gaining FDA approval for the first CAR-T cell therapy.
MDCO,MDCO:UW,BBG000DX6TV8,"AMGN's Endeavor Awaits Verdict, NVS Scripts History, OTIC Is Not Music To Ears",2017-08-31 02:36:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bBxkaP_xFs8/amgns-endeavor-awaits-verdict-nvs-scripts-history-otic-is-not-music-to-ears-20170831-00080,"AMGN's Endeavor Awaits Verdict, NVS Scripts History, OTIC Is Not Music To Ears"
MDCO,MDCO:UW,BBG000DX6TV8,"Medicines Company Gets FDA Approval, Has 119% Upside According To This Analyst",2017-08-30 17:22:46 +0000,https://finance.yahoo.com/news/medicines-company-gets-fda-approval-172246301.html?.tsrc=rss,The Medicines Company (NASDAQ: MDCO ) announced FDA approval for Vabomere injection to treat adult patients with complicated urinary tract infections. The company said the drug will be made available in ...
MDCO,MDCO:UW,BBG000DX6TV8,Otonomy Shares Fall On Disappointing Phase 3 Data - Biotech Movers,2017-08-30 13:46:00 +0000,http://finance.yahoo.com/r/aad88e1b-1351-3caf-9d12-0a5e4370009d/otonomy-shares-fall-on-disappointing-phase-3-data-biotech-movers.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,The San Diego firm said a Phase 3 study of Otividex in patients with Meniere's disease missed its primary endpoint.
MDCO,MDCO:UW,BBG000DX6TV8,"Health Care Sector Update for 08/30/2017: JNJ, PFE, ABT, MRK, AMGN, MDCO, OTIC",2017-08-30 13:29:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9E-EBgE9Rug/health-care-sector-update-for-08302017-jnj-pfe-abt-mrk-amgn-mdco-otic-cm839035,Top Health Care Stocks Top Health Care Stocks JNJ 0 2 JNJ 0 2 PFE flatPFE flat ABT flatABT flat MRK flatMRK flat AMGN 0 3 AMGN 0 3 Health care shares were mainly inactive in pre market trade Wednesday Health care shares were mainly inactive in pre market trade Wednesday In
MDCO,MDCO:UW,BBG000DX6TV8,Medicines Co. shares surge 2.5% on FDA approval of drug for complicated UTIs,2017-08-30 13:17:33 +0000,http://finance.yahoo.com/r/94891aff-3010-3cb8-8c65-c12d2a30b08e/Story.aspx?guid=EBA90FD6-1EDE-4599-8195-05744BF6598B&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Medicines Co. shares surged 2.5% in premarket trade Wednesday on news that the Food and Drug Administration has approved its injection for complicated urinary tract infections, including the kidney infection ..."
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company Announces FDA Approval of VABOMERE™ (meropenem and vaborbactam),2017-08-30 11:00:00 +0000,https://finance.yahoo.com/news/medicines-company-announces-fda-approval-110000553.html?.tsrc=rss,"The Medicines Company today announced that the U.S. Food and Drug Administration has approved VABOMERE™ for injection for the treatment of adult patients with complicated urinary tract infections , including pyelonephritis, caused by designated susceptible Enterobacteriaceae – Escherichia coli, Klebsiella pneumoniae and Enterobacter cloacae species complex."
MDCO,MDCO:UW,BBG000DX6TV8,Medicines Co.'s VABOMERE Approved By FDA For Adult Patients With CUTI,2017-08-30 07:24:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R_VIcjCkwgI/medicines-cos-vabomere-approved-by-fda-for-adult-patients-with-cuti-20170830-00299,Medicines Co.'s VABOMERE Approved By FDA For Adult Patients With CUTI
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Co's Inclisiran Positive in Extension Study,2017-08-29 23:49:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/b1S9tPbWAWI/the-medicines-cos-inclisiran-positive-in-extension-study-cm838889,The Medicines Company MDCO along with partner Alnylam Pharmaceuticals Inc ALNY announced new one year safety and efficacy data from the ongoing ORION 1 phase II study evaluating pipeline candidate Inclisiran PCSK9 Inhibitor for the treatment of hypercholesterolemia This new
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Co&apos;s Inclisiran Positive in Extension Study,2017-08-29 21:41:09 +0000,https://finance.yahoo.com/news/medicines-co-apos-inclisiran-positive-214109955.html?.tsrc=rss,The Medicines Company (MDCO) and partner Alnylam publish new one-year safety and efficacy data from phase II extension study of Inclisiran for hypercholesterolemia.
MDCO,MDCO:UW,BBG000DX6TV8,"The Medicines Co. breached its 50 day moving average in a Bullish Manner : MDCO-US : August 29, 2017",2017-08-29 12:42:25 +0000,http://finance.yahoo.com/r/e88cb1d6-752d-3c16-86f5-6ccd88469c82/the-medicines-co-breached-its-50-day-moving-average-in-a-bullish-manner-mdco-us-august-29-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for The Medicines Co.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish ... Read more
<b>(Read more...)</b>"
MDCO,MDCO:UW,BBG000DX6TV8,"New, One-Year Data from ORION-1 Phase II Study of Inclisiran Extends Excellent Long-Term Efficacy and Safety Profile, Affirming Dose for Phase III Trials",2017-08-28 11:00:00 +0000,https://finance.yahoo.com/news/one-data-orion-1-phase-110000444.html?.tsrc=rss,"The Medicines Company and Alnylam Pharmaceuticals, Inc. today announced new, positive data from the ORION-1 Phase II study of inclisiran, an investigational, first-in-class PCSK9 synthesis inhibitor being developed for the treatment of hypercholesterolemia."
MDCO,MDCO:UW,BBG000DX6TV8,Medicines Co. Announces New Data From ORION-1 Phase II Study Of Inclisiran,2017-08-28 07:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xW9r00EG_BQ/medicines-co-announces-new-data-from-orion1-phase-ii-study-of-inclisiran-20170828-00244,Medicines Co. Announces New Data From ORION-1 Phase II Study Of Inclisiran
MDCO,MDCO:UW,BBG000DX6TV8,See what the IHS Markit Score report has to say about Medicines Co.,2017-08-24 12:05:16 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120628963.html?.tsrc=rss,Medicines Co NASDAQ/NGS:MDCO
MDCO,MDCO:UW,BBG000DX6TV8,3 Biopharma Picks for Big Rewards with Less Risk,2017-08-23 23:38:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mYt6GBw1neM/3-biopharma-picks-for-big-rewards-with-less-risk-cm836271,InvestorPlace Stock Market News Stock Advice amp Trading Tips Investors may initially shy away from biopharma companies given the complexity of the science behind the treatments After all a company s stock will only do as well as their treatments pass FDA hurdles and are
MDCO,MDCO:UW,BBG000DX6TV8,First Week of MDCO April 2018 Options Trading,2017-08-22 16:41:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EbXtAqH96Qs/first-week-of-mdco-april-2018-options-trading-cm835402,Investors in Medicines Co Symbol MDCO saw new options begin trading this week for the April 2018 expiration One of the key data points that goes into the price an option buyer is willing to pay is the time value so with 241 days until expiration the newly trading contracts represent
MDCO,MDCO:UW,BBG000DX6TV8,Edited Transcript of MDCO earnings conference call or presentation 9-Aug-17 12:30pm GMT,2017-08-16 18:25:43 +0000,https://finance.yahoo.com/news/edited-transcript-mdco-earnings-conference-185636978.html?.tsrc=rss,Q2 2017 Medicines Co Earnings Call
MDCO,MDCO:UW,BBG000DX6TV8,See what the IHS Markit Score report has to say about Medicines Co.,2017-08-16 12:05:42 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120615739.html?.tsrc=rss,Medicines Co NASDAQ/NGS:MDCO
MDCO,MDCO:UW,BBG000DX6TV8,"Boxer Capital, LLC Buys Macrogenics Inc, G1 Therapeutics Inc, iPath S&P 500 VIX Short Term ...",2017-08-15 20:35:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CeIaXgeW0OY/boxer-capital-llc-buys-macrogenics-inc-g1-therapeutics-inc-ipath-sp-500-vix-short-term-cm832468,Boxer Capital LLC New Purchases MGNX GTHX VXX Added Positions PTCT LJPC SNSS SGEN Reduced Positions CLVS BPMC AVXS ESPR BGNE AQXP CBAY ONTX Sold Out ALNY ALXN ALDX ANAB AKTX ARDM NVET New Purchases MGNX
MDCO,MDCO:UW,BBG000DX6TV8,"Mallinckrodt (MNK) Looks Strong on Acthar, Generics Weak",2017-08-15 15:41:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QRYUCHkQiDU/mallinckrodt-mnk-looks-strong-on-acthar-generics-weak-cm832198,We issued an updated report on Mallinckrodt plc MNK on Aug 14 Mallinckrodt develops manufactures markets and distributes branded and generic specialty pharmaceutical and biopharmaceutical products and therapies as well as nuclear medicine products The company has been undertaking
MDCO,MDCO:UW,BBG000DX6TV8,See what the IHS Markit Score report has to say about Medicines Co.,2017-08-15 12:06:39 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120639550.html?.tsrc=rss,Medicines Co NASDAQ/NGS:MDCO
MDCO,MDCO:UW,BBG000DX6TV8,"Alnylam Pharmaceuticals, Inc. Earnings: Waiting for Apollo",2017-08-14 19:34:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SLaxo_QUn8I/alnylam-pharmaceuticals-inc-earnings-waiting-for-apollo-cm831838,Alnylam Pharmaceuticals NASDAQ ALNY reported 160 second quarter earnings last week and for the record the company lost 118 4 million but without any products on the market the focus of the earnings call was the biotech s pipeline and the potential for revenue in
MDCO,MDCO:UW,BBG000DX6TV8,See what the IHS Markit Score report has to say about Medicines Co.,2017-08-12 12:06:00 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120600941.html?.tsrc=rss,Medicines Co NASDAQ/NGS:MDCO
MDCO,MDCO:UW,BBG000DX6TV8,See what the IHS Markit Score report has to say about Medicines Co.,2017-08-11 12:05:18 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120518260.html?.tsrc=rss,Medicines Co NASDAQ/NGS:MDCO
MDCO,MDCO:UW,BBG000DX6TV8,"The Medicines Company (MDCO) Q2 Loss Widens, Revenues Miss",2017-08-10 22:37:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/of36tncPCgA/the-medicines-company-mdco-q2-loss-widens-revenues-miss-cm830606,The Medicines Company 160 MDCO reported second quarter 2017 loss of 5 52 per share massively wider than the Zacks Consensus Estimate of a loss of 1 29 However adjusted loss per share was 1 02 excluding the impact of share based compensation expenses versus a loss of 69 cents in
MDCO,MDCO:UW,BBG000DX6TV8,"Alnylam (ALNY) Q2 Loss Narrower than Expected, Sales Miss",2017-08-10 22:36:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VDi00Dw7axU/alnylam-alny-q2-loss-narrower-than-expected-sales-miss-cm830594,Alnylam Pharmaceuticals Inc ALNY reported a loss of 1 34 per share in the second quarter of 2017 narrower than the Zacks Consensus Estimate of a loss of 1 45 but wider than the year ago loss of 1 05 Alnylam Pharmaceuticals Inc Price and EPS
MDCO,MDCO:UW,BBG000DX6TV8,"Alnylam (ALNY) Q2 Loss Narrower than Expected, Sales Miss",2017-08-10 20:31:08 +0000,https://finance.yahoo.com/news/alnylam-alny-q2-loss-narrower-203108127.html?.tsrc=rss,Alnylam&apos;s (ALNY) second-quarter results were mixed with the company reporting a narrower-than-expected loss but sales missed estimates.
MDCO,MDCO:UW,BBG000DX6TV8,"The Medicines Company (MDCO) Q2 Loss Widens, Revenues Miss",2017-08-10 20:10:08 +0000,https://finance.yahoo.com/news/medicines-company-mdco-q2-loss-201008736.html?.tsrc=rss,The Medicines Company (MDCO) reports wider-than-expected loss with revenues missing estimates. The top line also decreases year over year due to low Angiomax sales.
MDCO,MDCO:UW,BBG000DX6TV8,See what the IHS Markit Score report has to say about Medicines Co.,2017-08-10 12:06:11 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120611241.html?.tsrc=rss,Medicines Co NASDAQ/NGS:MDCO
MDCO,MDCO:UW,BBG000DX6TV8,Medicines Co. reports 2Q loss,2017-08-10 02:59:07 +0000,https://finance.yahoo.com/news/medicines-co-reports-2q-loss-111256573.html?.tsrc=rss,"The Parsippany, New Jersey-based company said it had a loss of $5.52 per share. The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research ..."
MDCO,MDCO:UW,BBG000DX6TV8,See what the IHS Markit Score report has to say about Medicines Co.,2017-08-09 12:06:37 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120637133.html?.tsrc=rss,Medicines Co NASDAQ/NGS:MDCO
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company Reports Second Quarter 2017 Business and Financial Results,2017-08-09 11:00:00 +0000,https://finance.yahoo.com/news/medicines-company-reports-second-quarter-110000681.html?.tsrc=rss,"The Medicines Company today reported its financial results for the second quarter ended June 30, 2017, and provided an update on its clinical and operational activities."
MDCO,MDCO:UW,BBG000DX6TV8,Investor Network: Medicines Company to Host Earnings Call,2017-08-09 09:30:00 +0000,https://finance.yahoo.com/news/investor-network-medicines-company-host-093000701.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 9, 2017 / Medicines Company (NASDAQ: MDCO ) will be discussing their earnings results in their Q2 Earnings Call to be held on Wednesday, August 9, 2017 at 8:30 AM Eastern ..."
MDCO,MDCO:UW,BBG000DX6TV8,"Mallinckrodt (MNK) Tops Q2 Earnings, Generics Segment Weak",2017-08-08 19:36:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yGT4pTAfOJQ/mallinckrodt-mnk-tops-q2-earnings-generics-segment-weak-cm828979,Mallinckrodt Public Limited Company MNK reported second quarter 2017 results wherein earnings beat expectations but sales missed the same The company reported adjusted earnings of 1 85 per share in the reported quarter beating the Zacks Consensus Estimate of 1 73 Earnings were however
MDCO,MDCO:UW,BBG000DX6TV8,"The Medicines Co. – Value Analysis (NASDAQ:MDCO) : August 5, 2017",2017-08-05 01:08:45 +0000,http://finance.yahoo.com/r/7c6c1e96-517a-3e5d-a7ca-ee69331df539/the-medicines-co-value-analysis-nasdaqmdco-august-5-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives The Medicines Co. a score of 19. Our analysis is based on comparing The Medicines Co. with the following peers – Innoviva, Inc., Momenta Pharmaceuticals, Inc., Vericel Corporation, Teva Pharmaceutical Industries Limited Sponsored ADR, Eagle Pharmaceuticals, Inc., Pfizer Inc., Johnson & Johnson, Eli Lilly and Company, Bristol-Myers ... Read more
<b>(Read more...)</b>"
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company to Announce Second-Quarter 2017 Financial Results on August 9,2017-07-31 11:00:00 +0000,https://finance.yahoo.com/news/medicines-company-announce-second-quarter-110000461.html?.tsrc=rss,"The Medicines Company will host a conference call on Wednesday, August 9, 2017, at 8:30 a.m., Eastern Daylight Time, to discuss its second-quarter 2017 financial results and operational developments."
MDCO,MDCO:UW,BBG000DX6TV8,"Biotech Stock Roundup: Amgen, Biogen Top Q2 Estimates, Update on Incyte RA Drug",2017-07-26 14:03:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/02xDNr1AwQk/biotech-stock-roundup-amgen-biogen-top-q2-estimates-update-on-incyte-ra-drug-cm821419,Key biotech stocks Amgen AMGN and Biogen BIIB reported second quarter results yesterday both companies surpassed earnings and sales estimates There were several other key updates as well from companies like Incyte INCY and The Medicines Co MDCO 160 Recap of the Week s
MDCO,MDCO:UW,BBG000DX6TV8,"Biotech Stock Roundup: Amgen, Biogen Top Q2 Estimates, Update on Incyte RA Drug",2017-07-26 12:15:12 +0000,https://finance.yahoo.com/news/biotech-stock-roundup-amgen-biogen-121512704.html?.tsrc=rss,Earnings season kicked off on a positive note for biotech stocks with big players like Amgen (AMGN) and Biogen reporting better than expected results.
MDCO,MDCO:UW,BBG000DX6TV8,"Positive Data IGNITEs TTPH, MDCO Makes A Good TANGO, Wait Continues For EGRX",2017-07-26 02:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2TRAnoGhx_E/positive-data-ignites-ttph-mdco-makes-a-good-tango-wait-continues-for-egrx-20170726-00106,"Positive Data IGNITEs TTPH, MDCO Makes A Good TANGO, Wait Continues For EGRX"
MDCO,MDCO:UW,BBG000DX6TV8,Biotech Movers: Novavax Falls Again After New Data on RSV Vaccine Fails to Excite,2017-07-25 16:35:00 +0000,http://finance.yahoo.com/r/7727bfd0-5fdc-33bd-855e-e3afca0bdc8c/biotech-movers-novavax-falls-again-after-new-data-on-rsv-vaccine-fails-to-excite.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Novavax, Medicines Co. and Biogen were among the biotech stock movers in premarket trading on July 25."
MDCO,MDCO:UW,BBG000DX6TV8,"The Medicines Company announces TANGO-2 trial of meropenem-vaborbactam (formerly, Carbavance) stopped early for superior benefit-risk compared to best available therapy for CRE",2017-07-25 11:00:00 +0000,https://finance.yahoo.com/news/medicines-company-announces-tango-2-110000267.html?.tsrc=rss,"The Medicines Company today announced positive results from an interim analysis of the TANGO-2 trial of its fixed-dose, investigational antibiotic combination, meropenem-vaborbactam."
MDCO,MDCO:UW,BBG000DX6TV8,"The Medicines Co. breached its 50 day moving average in a Bullish Manner : MDCO-US : July 24, 2017",2017-07-24 12:28:33 +0000,http://finance.yahoo.com/r/8337ed01-adf2-3f35-8c4a-f91c30d9e0c1/the-medicines-co-breached-its-50-day-moving-average-in-a-bullish-manner-mdco-us-july-24-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for The Medicines Co.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish ... Read more
<b>(Read more...)</b>"
MDCO,MDCO:UW,BBG000DX6TV8,Are Medicines Company's Key Drugs Set for Growth in 2017?,2017-07-10 22:45:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DPnlWTr89fg/are-medicines-companys-key-drugs-set-for-growth-in-2017-cm814118,On Jul 7 2017 we issued an updated report on The Medicines Company MDCO The Medicines Co is a global biopharmaceutical company focused on advancing the treatment of critical care patients through delivery of innovative cost effective medicines to the worldwide hospital
MDCO,MDCO:UW,BBG000DX6TV8,Are Medicines Company&apos;s Key Drugs Set for Growth in 2017?,2017-07-10 20:50:08 +0000,https://finance.yahoo.com/news/medicines-company-apos-key-drugs-205008934.html?.tsrc=rss,"On Jul 7, 2017, we issued an updated report on The Medicines Company (MDCO)."
MDCO,MDCO:UW,BBG000DX6TV8,Medicines is Now Oversold,2017-06-12 22:26:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JipmTy06BKA/medicines-is-now-oversold-cm802354,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
MDCO,MDCO:UW,BBG000DX6TV8,Why Is Alnylam (ALNY) Up 31.2% Since the Last Earnings Report?,2017-06-08 07:31:07 +0000,https://finance.yahoo.com/news/why-alnylam-alny-31-2-073107537.html?.tsrc=rss,Alnylam (ALNY) reported earnings 30 days ago. What&apos;s next for the stock? We take a look at earnings estimates for some clues.
MDCO,MDCO:UW,BBG000DX6TV8,Edited Transcript of MDCO earnings conference call or presentation 26-Apr-17 12:30pm GMT,2017-06-07 04:15:59 +0000,https://finance.yahoo.com/news/edited-transcript-mdco-earnings-conference-192643942.html?.tsrc=rss,Q1 2017 Medicines Co Earnings Call
MDCO,MDCO:UW,BBG000DX6TV8,Dr. Reddy's Launches Angiomax' Generic Bivalirudin For Injection In U.S.,2017-06-06 04:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Yx6xUAHPXK4/dr-reddys-launches-angiomax-generic-bivalirudin-for-injection-in-us-20170606-00107,Dr. Reddy's Launches Angiomax' Generic Bivalirudin For Injection In U.S.
MDCO,MDCO:UW,BBG000DX6TV8,Medicines Co. To Cut 15% Of Workforce As It Discontinues IONSYS In The U.S.,2017-06-03 23:11:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IVn8mlumYhM/medicines-co-to-cut-15-of-workforce-as-it-discontinues-ionsys-in-the-us-20170603-00034,Medicines Co. To Cut 15% Of Workforce As It Discontinues IONSYS In The U.S.
MDCO,MDCO:UW,BBG000DX6TV8,"Top Losers in the Healthcare Sector: May 22–26, 2017",2017-05-31 16:01:33 +0000,http://finance.yahoo.com/r/547c1ea6-b28f-3436-b92c-632256284434/top-losers-in-the-healthcare-sector-may-22-26-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"During the week ended May 26, 2017, Alexion Pharmaceuticals (ALXN) saw the biggest loss in the healthcare sector. ALXN's stock price witnessed a steep fall of ~14.2%."
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company to Present Data at ASM Microbe 2017 on Infectious Disease Portfolio Including Late-Stage Investigational Antibiotic Meropenem-Vaborbactam,2017-05-30 20:30:00 +0000,https://finance.yahoo.com/news/medicines-company-present-data-asm-203000568.html?.tsrc=rss,"The Medicines Company today announced that data from its portfolio of antimicrobial products and late-stage product candidates will be featured in presentations at the American Society for Microbiology’s ASM Microbe 2017 to be held June 1-5, 2017 in New Orleans."
MDCO,MDCO:UW,BBG000DX6TV8,Regeneron Presents Positive Phase II Data on HoFH Candidate,2017-05-25 16:32:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5bupxEfVXGY/regeneron-presents-positive-phase-ii-data-on-hofh-candidate-cm794606,Regeneron Pharmaceuticals Inc REGN presented positive phase II data evaluating its investigational angiopoietin like 3 ANGPTL3 antibody evinacumab at the National Lipid Association s NLA Scientific Sessions The company also announced ANGPTL3 genetics publication in the New
MDCO,MDCO:UW,BBG000DX6TV8,Regeneron Presents Positive Phase II Data on HoFH Candidate,2017-05-25 14:27:02 +0000,https://finance.yahoo.com/news/regeneron-presents-positive-phase-ii-142702129.html?.tsrc=rss,"Regeneron Pharmaceuticals, Inc. (REGN) presented positive phase II data, evaluating its investigational angiopoietin-like 3 (ANGPTL3) antibody, evinacumab at the National Lipid Association&apos;s (NLA) Scientific Sessions."
MDCO,MDCO:UW,BBG000DX6TV8,Medicines Breaks Below 200-Day Moving Average - Notable for MDCO,2017-05-22 18:13:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1tZB2Eh4Nkc/medicines-breaks-below-200-day-moving-average-notable-for-mdco-cm792796,In trading on Monday shares of Medicines Co Symbol MDCO crossed below their 200 day moving average of 41 57 changing hands as low as 40 50 per share Medicines Co shares are currently trading down about 4 1 on the day The chart below shows the one year performance of MDCO shares
MDCO,MDCO:UW,BBG000DX6TV8,"ETFs with exposure to The Medicines Co. : May 22, 2017",2017-05-22 17:52:36 +0000,http://finance.yahoo.com/r/21869290-6b24-33c9-aca9-fa968bc863c6/etfs-with-exposure-to-the-medicines-co-may-22-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to The Medicines Co. Here are 5 ETFs with the largest exposure to MDCO-US. Comparing the performance and risk of The Medicines Co. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
MDCO,MDCO:UW,BBG000DX6TV8,This Fund’s Picks Gained 200% In A Year And Why No One Knows About It,2017-05-16 20:51:01 +0000,http://finance.yahoo.com/r/04c47290-fb3c-36dd-bc6c-e564cc4eecee/this-funds-picks-gained-200-in-a-year-and-why-no-one-knows-about-it-581306?yptr=yahoo&.tsrc=rss,"You probably haven’t heard of Alex Denner‘s Sarissa Capital Management, which is a shame, as the fund is coming off a first-quarter in which its stock picks in companies valued at $1 billion or more delivered weighted average returns of 53.2%, pushing its 1-year returns to an even 200%. With the media paying most of […]"
MDCO,MDCO:UW,BBG000DX6TV8,"ETFs with exposure to The Medicines Co. : May 11, 2017",2017-05-11 21:06:25 +0000,http://finance.yahoo.com/r/26798b33-a357-3cc4-8edc-1522bffbae9c/etfs-with-exposure-to-the-medicines-co-may-11-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to The Medicines Co. Here are 5 ETFs with the largest exposure to MDCO-US. Comparing the performance and risk of The Medicines Co. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
MDCO,MDCO:UW,BBG000DX6TV8,"Alnylam Pharmaceuticals, Inc. Earnings: All Eyes on APOLLO",2017-05-10 22:03:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oBNttubzHQc/alnylam-pharmaceuticals-inc-earnings-all-eyes-on-apollo-cm787535,Alnylam Pharmaceuticals NASDAQ ALNY released first quarter earnings on Friday but without any drugs on the market investors are rightfully focused on the biotech s pipeline Alnylam Pharmaceuticals results The only number that really
MDCO,MDCO:UW,BBG000DX6TV8,"The Medicines Co. :MDCO-US: Earnings Analysis: Q1, 2017 By the Numbers : May 9, 2017",2017-05-09 15:19:50 +0000,http://finance.yahoo.com/r/9fdb1035-a47e-3da7-a11e-1ac917ea9f67/the-medicines-co-mdco-us-earnings-analysis-q1-2017-by-the-numbers-may-9-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis The Medicines Co. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of The Medicines Co. – Innoviva, Inc., Momenta Pharmaceuticals, Inc., Pfizer Inc., Astrazeneca PLC Sponsored ADR, Johnson & Johnson, Bristol-Myers Squibb Company and Eli Lilly and Company (INVA-US, MNTA-US, ... Read more
<b>(Read more...)</b>"
MDCO,MDCO:UW,BBG000DX6TV8,"Alnylam (ALNY) Q1 Loss Wider than Expected, Revenues Up Y/Y",2017-05-08 20:03:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WBGwk4Yjl4E/alnylam-alny-q1-loss-wider-than-expected-revenues-up-yy-cm786085,Alnylam Pharmaceuticals Inc ALNY reported a loss of 1 25 per share in the first quarter of 2017 wider than the Zacks Consensus Estimate of a loss of 1 22 and the year ago loss of 1 21 Quarterly revenues rose 160 3 to 19 0 million However revenues missed the Zacks Consensus
MDCO,MDCO:UW,BBG000DX6TV8,"Mallinckrodt Earnings, Revenues Beat Estimates in Q1",2017-05-08 20:02:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pm1rg4F5og0/mallinckrodt-earnings-revenues-beat-estimates-in-q1-cm786073,Mallinckrodt Public Limited Company MNK reported first quarter 2017 results wherein both 160 sales and earnings beat expectations The company reported adjusted earnings of 1 68 per share in the reported quarter beating the Zacks Consensus Estimate of 1 63 Earnings were however down
MDCO,MDCO:UW,BBG000DX6TV8,"Alnylam (ALNY) Q1 Loss Wider than Expected, Revenues Up Y/Y",2017-05-08 17:59:05 +0000,http://finance.yahoo.com/news/alnylam-alny-q1-loss-wider-175905786.html?.tsrc=rss,"Alnylam Pharmaceuticals, Inc. (ALNY) reported a loss of $1.25 per share in the first quarter of 2017, wider than the Zacks Consensus Estimate of a loss of $1.22 and the year-ago loss of $1.21."
MDCO,MDCO:UW,BBG000DX6TV8,Do Options Traders Know Something About Medicines Company (MDCO) Stock We Don't?,2017-05-08 14:48:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SlQ-W3br7NM/do-options-traders-know-something-about-medicines-company-mdco-stock-we-dont-cm785708,Investors in The Medicines Company MDCO need to pay close attention to the stock based on moves in the options market lately That is because the June 16 th 2017 60 Call had some of the highest implied volatility of all equity options today What is Implied Volatility
MDCO,MDCO:UW,BBG000DX6TV8,Do Options Traders Know Something About Medicines Company (MDCO) Stock We Don&apos;t?,2017-05-08 12:47:12 +0000,http://finance.yahoo.com/news/options-traders-know-something-medicines-124712376.html?.tsrc=rss,Investors in The Medicines Company (MDCO) need to pay close attention to the stock based on moves in the options market lately.
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company to Participate in the Bank of America Merrill Lynch 2017 Health Care Conference,2017-05-04 11:00:00 +0000,http://finance.yahoo.com/news/medicines-company-participate-bank-america-110000233.html?.tsrc=rss,"The Medicines Company today announced that it will participate in the Bank of America Merrill Lynch 2017 Health Care Conference on Tuesday, May 16, 2017, in Las Vegas, Nevada."
MDCO,MDCO:UW,BBG000DX6TV8,What's in Store for Mallinckrodt (MNK) This Earnings Season?,2017-05-03 23:10:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/P2vG1nwYXO0/whats-in-store-for-mallinckrodt-mnk-this-earnings-season-cm783827,Mallinckrodt plc MNK is set to report first quarter fiscal 2017 results on May 8 The company s track record has been impressive so far Mallinckrodt delivered a positive average earnings surprise of 8 7 in the last four trailing quarters Let s see how things are shaping up for
MDCO,MDCO:UW,BBG000DX6TV8,"After Hours Most Active for May 3, 2017 :  FB, SQ, QQQ, HPE, CSCO, MOS, WFT, LB, KR, CG, MDCO, ADSK",2017-05-03 20:58:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/q40SCtCXc6s/after-hours-most-active-for-may-3-2017-fb-sq-qqq-hpe-csco-mos-wft-lb-kr-cg-mdco-adsk-cm783793,The NASDAQ 100 After Hours Indicator is down 15 4 to 5 609 76 The total After hours volume is currently 41 494 344 shares traded The following are the most active stocks for the after hours session Facebook Inc FB is 3 05 at 148 75 with 3 955 492 shares
MDCO,MDCO:UW,BBG000DX6TV8,iShares Core S&P Small-Cap ETF Experiences Big Inflow,2017-05-03 19:47:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-iwpRPAQFb8/ishares-core-sp-small-cap-etf-experiences-big-inflow-cm783583,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Core S amp P Small Cap ETF Symbol IJR where we have detected an approximate 126 3 million dollar inflow that s a 0 4 increase week over week
MDCO,MDCO:UW,BBG000DX6TV8,Implied FTXH Analyst Target Price: $24,2017-05-03 13:27:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H8ztPYeqQIE/implied-ftxh-analyst-target-price-24-cm783384,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
MDCO,MDCO:UW,BBG000DX6TV8,"Signpost Capital Advisors, LP Buys TripAdvisor, Sells Calpine, DaVita, The Medicines Co",2017-05-02 13:25:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wzUNo6zpNzk/signpost-capital-advisors-lp-buys-tripadvisor-sells-calpine-davita-the-medicines-co-cm782545,Signpost Capital Advisors LP Added Positions TRIP Reduced Positions CPN DVA MDCO SRG RTRX ALNY Added Positions TRIP Added Positions TRIP Reduced Positions CPN DVA MDCO SRG RTRX ALNY Reduced Positions
MDCO,MDCO:UW,BBG000DX6TV8,Edited Transcript of MDCO earnings conference call or presentation 26-Apr-17 12:30pm GMT,2017-04-29 12:30:55 +0000,http://finance.yahoo.com/news/edited-transcript-mdco-earnings-conference-192643942.html?.tsrc=rss,Q1 2017 Medicines Co Earnings Call
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company (MDCO) Q1 Loss Wider Than Expected,2017-04-27 15:29:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/D99dWKkZ4m4/the-medicines-company-mdco-q1-loss-wider-than-expected-cm780246,The Medicines Company MDCO reported a loss of 1 44 per share in first quarter 2017 wider than the Zacks Consensus Estimate of a loss of 1 13 Including share based compensation expenses however adjusted loss was 1 14 per share The reported figure widened from the year ago loss of 1
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company (MDCO) Q1 Loss Wider Than Expected,2017-04-27 13:52:01 +0000,http://finance.yahoo.com/news/medicines-company-mdco-q1-loss-135201734.html?.tsrc=rss,"The Medicines Company (MDCO) reported loss $1.44 per share, wider than the Zacks Consensus Estimate of a loss of $1.13."
MDCO,MDCO:UW,BBG000DX6TV8,Blog Coverage Medicines Co. Reaches Agreement with FDA for the Phase III Trial for Inclisiran,2017-04-27 12:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-medicines-co-reaches-121500891.html?.tsrc=rss,"LONDON, UK / ACCESSWIRE / April 27, 2017 / Active Wall St. blog coverage looks at the headline from The Medicines Co. (NASDAQ: MDCO ) and Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ). On April 26, 2017, ..."
MDCO,MDCO:UW,BBG000DX6TV8,"Amgen Trips Amid Rivals: Sales Miss By $100 Million, But Earnings Top",2017-04-26 21:28:43 +0000,http://finance.yahoo.com/r/d7fb9886-3e96-3874-b039-5cea66ab5ed9/amgen-q1-profits-top-but-sales-miss-by-100-million?src=A00220&yptr=yahoo&.tsrc=rss,Amgen stock toppled in after-hours trading Wednesday after reporting first-quarter sales that missed by $100 million on increased competition for several drugs.
MDCO,MDCO:UW,BBG000DX6TV8,"The Medicines Co. – Value Analysis (NASDAQ:MDCO) : April 26, 2017",2017-04-26 20:17:11 +0000,http://finance.yahoo.com/r/6c98ea6e-d5aa-3859-87be-07da6ced3ee1/the-medicines-co-value-analysis-nasdaqmdco-april-26-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives The Medicines Co. a score of 19. Our analysis is based on comparing The Medicines Co. with the following peers – Innoviva, Inc., Eagle Pharmaceuticals, Inc., Momenta Pharmaceuticals, Inc., Pfizer Inc., Teva Pharmaceutical Industries Limited Sponsored ADR, Vericel Corporation, Astrazeneca PLC Sponsored ADR, Johnson & Johnson, Bristol-Myers ... Read more
<b>(Read more...)</b>"
MDCO,MDCO:UW,BBG000DX6TV8,"Notable ETF Inflow Detected - IJR, MDCO, BLKB, MKSI",2017-04-26 16:06:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Qd6omEBgF68/notable-etf-inflow-detected-ijr-mdco-blkb-mksi-cm779544,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Core S amp P Small Cap ETF Symbol IJR where we have detected an approximate 102 0 million dollar inflow that s a 0 3 increase week over week
MDCO,MDCO:UW,BBG000DX6TV8,Medicines Co. reports 1Q loss,2017-04-26 11:36:36 +0000,http://finance.yahoo.com/news/medicines-co-reports-1q-loss-113636990.html?.tsrc=rss,"The Parsippany, New Jersey-based company said it had a loss of $1.44 per share. The results fell short of Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research ..."
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company Reports First-Quarter 2017 Financial Results,2017-04-26 11:15:00 +0000,http://finance.yahoo.com/news/medicines-company-reports-first-quarter-111500525.html?.tsrc=rss,"The Medicines Company  today announced its business and financial results for the first-quarter ended March 31, 2017."
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company and Alnylam Pharmaceuticals Announce Agreement with FDA on Phase III Clinical Program for Inclisiran,2017-04-26 11:00:00 +0000,http://finance.yahoo.com/news/medicines-company-alnylam-pharmaceuticals-announce-110000255.html?.tsrc=rss,"The Medicines Company and Alnylam Pharmaceuticals, Inc. today announced that The Medicines Company has agreed with the U.S. Food and Drug Administration on plans for the Phase III clinical program for inclisiran, which is designed to support the submission of a New Drug Application ."
MDCO,MDCO:UW,BBG000DX6TV8,"The Medicines Co. breached its 50 day moving average in a Bearish Manner : MDCO-US : April 25, 2017",2017-04-25 13:31:41 +0000,http://finance.yahoo.com/r/0250acb4-8b93-3d5a-878b-b4f6ac0f661c/the-medicines-co-breached-its-50-day-moving-average-in-a-bearish-manner-mdco-us-april-25-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for The Medicines Co.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more
<b>(Read more...)</b>"
MDCO,MDCO:UW,BBG000DX6TV8,"Drug Stocks Q1 Earnings Releases on Apr 26: AMGN, GSK & More",2017-04-25 13:08:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ghSfv9yzOB4/drug-stocks-q1-earnings-releases-on-apr-26-amgn-gsk-more-cm778424,The Q1 earnings season is in full swing and we believe this quarter is on track to see the highest growth in almost three years According to the Earnings Preview report 95 S amp P 500 members accounting for 24 9 of the index s total market capitalization have reported results as of Apr
MDCO,MDCO:UW,BBG000DX6TV8,"Drug Stocks Q1 Earnings Releases on Apr 26: AMGN, GSK & More",2017-04-25 10:50:10 +0000,http://finance.yahoo.com/news/drug-stocks-q1-earnings-releases-105010141.html?.tsrc=rss,Here we have four pharma companies that are set to report first-quarter results on Apr 26. Let&apos;s see how things are shaping up for this quarter.
MDCO,MDCO:UW,BBG000DX6TV8,"Notable Friday Option Activity: MDCO, EXPE, RLGY",2017-04-21 17:03:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7ECYm4hSv34/notable-friday-option-activity-mdco-expe-rlgy-cm777150,Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Medicines Co Symbol MDCO where a total of 11 900 contracts have traded so far representing approximately 1 2 million underlying shares That amounts to about 92 2 of MDCO s
MDCO,MDCO:UW,BBG000DX6TV8,"Biotech Stock Roundup: FDA CRL Hits Incyte, Pipeline Setbacks Weigh on OncoMed",2017-04-19 14:06:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ElHVpLVTn4U/biotech-stock-roundup-fda-crl-hits-incyte-pipeline-setbacks-weigh-on-oncomed-cm775728,The FDA s complete response letter CRL for Incyte INCY and Lilly s experimental rheumatoid arthritis RA treatment was the big news in the biotech sector while OncoMed OMED continued to be hit by more pipeline setbacks Recap of the Week s Most Important Stories CRL for Incyte s
MDCO,MDCO:UW,BBG000DX6TV8,UnitedHealth (UNH) Q1 Earnings Beat on Membership Growth,2017-04-18 15:05:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bHaARRU0K1U/unitedhealth-unh-q1-earnings-beat-on-membership-growth-cm775260,UnitedHealth Group Inc UNH reported first quarter net operating earnings per share of 2 37 comfortably beating the Zacks Consensus Estimate of 2 18 and increasing 31 year over year Higher revenues strength in both the segments UnitedHealthcare and Optum and membership growth
MDCO,MDCO:UW,BBG000DX6TV8,UnitedHealth (UNH) Poised to Beat on Q1 Earnings: Here's Why,2017-04-17 14:58:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/g_aj3mSE-RY/unitedhealth-unh-poised-to-beat-on-q1-earnings-heres-why-cm774543,We expect UnitedHealth Group Inc UNH to beat earnings expectations when it reports first quarter results on Apr 18 before the opening bell Why a Likely Positive Surprise Our proven model shows that UnitedHealth has the right combination of the two key ingredients to beat on
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company to Present Data at ECCMID 2017 on Infectious Disease Portfolio Including Investigational Antibiotic Meropenem-Vaborbactam,2017-04-17 11:00:00 +0000,http://finance.yahoo.com/news/medicines-company-present-data-eccmid-110000262.html?.tsrc=rss,"The Medicines Company today announced that data from its portfolio of antimicrobial products and late-stage product candidates will be featured in presentations at the 27th Annual European Congress of Clinical Microbiology and Infectious Diseases to be held April 22-25, 2017, in Vienna, Austria."
MDCO,MDCO:UW,BBG000DX6TV8,iShares Core S&P Small-Cap ETF Experiences Big Inflow,2017-04-13 16:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nCo6dd60KAY/ishares-core-sp-small-cap-etf-experiences-big-inflow-cm773872,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Core S amp P Small Cap ETF Symbol IJR where we have detected an approximate 206 4 million dollar inflow that s a 0 7 increase week over week
MDCO,MDCO:UW,BBG000DX6TV8,"The Medicines Company to Announce First-Quarter 2017 Financial Results on April 26, 2017",2017-04-12 20:30:00 +0000,http://finance.yahoo.com/news/medicines-company-announce-first-quarter-203000791.html?.tsrc=rss,"The Medicines Company will host a conference call on Wednesday, April 26, 2017, at 8:30 a.m., Eastern Daylight Time, to discuss first-quarter 2017 financial results and operational developments."
MDCO,MDCO:UW,BBG000DX6TV8,Regeneron's Evinacumab Gets Breakthrough Therapy by FDA,2017-04-07 16:54:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6RT332GkS4U/regenerons-evinacumab-gets-breakthrough-therapy-by-fda-cm771439,Regeneron Pharmaceuticals Inc REGN announced that the FDA has granted Breakthrough Therapy Designation status to its pipeline candidate evinacumab for the treatment of hypercholesterolemia in patients with Homozygous Familial Hypercholesterolemia HoFH Notably HoFH is an inherited
MDCO,MDCO:UW,BBG000DX6TV8,Regeneron&apos;s Evinacumab Gets Breakthrough Therapy by FDA,2017-04-07 14:36:02 +0000,http://finance.yahoo.com/news/regeneron-apos-evinacumab-gets-breakthrough-143602857.html?.tsrc=rss,"Regeneron Pharmaceuticals, Inc. (REGN) announced that the FDA has granted Breakthrough Therapy Designation status to ievinacumab for the treatment patients with Homozygous Familial Hypercholesterolemia."
MDCO,MDCO:UW,BBG000DX6TV8,Federal appeals court rules Mylan can proceed with generic Angiomax,2017-04-06 18:03:43 +0000,http://finance.yahoo.com/news/federal-appeals-court-rules-mylan-180343212.html?.tsrc=rss,A U.S. appeals court ruled that Mylan  Inc's proposed generic version of the blood thinner  Angiomax would not infringe on patents held by The Medicines  Company.  The U.S. Court of Appeals for the Federal Circuit reversed a  decision by a federal judge in Illinois who ruled for The  Medicines Company.  Angiomax is The Medicines Company's top product.
MDCO,MDCO:UW,BBG000DX6TV8,"Former Ariad CEO joins a familiar face on board of The Medicines Co., hinting at a sale",2017-04-06 10:41:15 +0000,http://finance.yahoo.com/r/554fe246-e326-3f09-82b2-a392e6be949e/former-ariad-ceo-joins-a-familiar-face-on-board-of.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"The former CEO of Ariad Pharmaceuticals Inc., who spent the last year shaping up the Cambridge-based drug company for its $5.2 acquisition earlier this year, was just named to the board of a new biotech last week.  There, as the newest board member of New Jersey-based The Medicines Company, Paris Panayiotopoulos joins a familiar face: Alex Denner, former chairman of Ariad (ARIA).  The founder of hedge fund Sarissa Capital, an activist investor believed to have played a big role in orchestrating the sale of that company, was named to that same 11-member board just over a year ago."
MDCO,MDCO:UW,BBG000DX6TV8,Three Small Caps to Buy for the Second Quarter,2017-04-05 16:35:00 +0000,http://finance.yahoo.com/r/7d598c72-41d2-3239-922a-deb6ef7abf9e/three-small-caps-buy-second-quarter-bobe-mdco?partner=YahooSA&yptr=yahoo&.tsrc=rss,Buying the strongest small-cap components could offer a more profitable second-quarter strategy than picking up the Russell-2000 index fund.
MDCO,MDCO:UW,BBG000DX6TV8,5 Deadliest Diseases in the U.S. -- and the Top Drugs Potentially on the Way to Treat Them,2017-04-02 11:23:00 +0000,https://www.fool.com/investing/2017/04/02/5-deadliest-diseases-in-the-us-and-the-top-drugs-p.aspx,5 Deadliest Diseases in the U.S. -- and the Top Drugs Potentially on the Way to Treat Them
MDCO,MDCO:UW,BBG000DX6TV8,5 Deadliest Diseases in the U.S. -- and the Top Drugs Potentially on the Way to Treat Them,2017-04-02 11:23:00 +0000,http://finance.yahoo.com/r/58ac3440-3f9d-385a-ad3a-27f1c34c8411/5-deadliest-diseases-in-the-us-and-the-top-drugs-p.aspx?yptr=yahoo&.tsrc=rss,Promising treatments could be on the way to address the diseases causing the most American deaths.
MDCO,MDCO:UW,BBG000DX6TV8,"MEDICINES CO /DE Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits",2017-03-31 18:27:34 +0000,http://biz.yahoo.com/e/170331/mdco8-k.html,"MEDICINES CO /DE Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits"
MDCO,MDCO:UW,BBG000DX6TV8,Why Is  Medicines Company (MDCO) Down 5.1% Since the Last Earnings Report?,2017-03-31 13:02:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lczEYZGL7Po/why-is-medicines-company-mdco-down-51-since-the-last-earnings-report-cm768134,A month has gone by since the last earnings report for The Medicines Company MDCO Shares have lost about 5 1 in that time frame underperforming the market Will the recent negative trend continue leading up to the stock s next earnings release or is it due for a breakout Before we
MDCO,MDCO:UW,BBG000DX6TV8,Why Is Medicines Company (MDCO) Down 5.1% Since the Last Earnings Report?,2017-03-31 11:18:11 +0000,http://finance.yahoo.com/news/why-medicines-company-mdco-down-111811328.html?.tsrc=rss,Medicines Company (MDCO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
MDCO,MDCO:UW,BBG000DX6TV8,Why Is Medicines Company (MDCO) Down 5.1% Since the Last Earnings Report?,2017-03-31 11:18:11 +0000,http://finance.yahoo.com/news/why-medicines-company-mdco-down-111811328.html,Why Is Medicines Company (MDCO) Down 5.1% Since the Last Earnings Report?
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company Appoints Paris Panayiotopoulos to Its Board of Directors,2017-03-31 11:00:00 +0000,http://finance.yahoo.com/news/medicines-company-appoints-paris-panayiotopoulos-110000371.html,"[Business Wire] - The Medicines Company today announced that it has appointed Paris Panayiotopoulos to its Board of Directors. Mr. Panayiotopoulos, who will serve as a Class I director, will stand for election at the Company’s 2017 Annual Meeting of Stockholders."
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company Appoints Paris Panayiotopoulos to Its Board of Directors,2017-03-31 11:00:00 +0000,http://finance.yahoo.com/news/medicines-company-appoints-paris-panayiotopoulos-110000371.html?.tsrc=rss,"The Medicines Company today announced that it has appointed Paris Panayiotopoulos to its Board of Directors. Mr. Panayiotopoulos, who will serve as a Class I director, will stand for election at the Company’s 2017 Annual Meeting of Stockholders."
MDCO,MDCO:UW,BBG000DX6TV8,The 3 Best Cholesterol Drug Stocks to Buy in 2017,2017-03-30 21:59:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KE6xzQP6vr8/the-3-best-cholesterol-drug-stocks-to-buy-in-2017-cm768027,No cholesterol drug is likely to ever reach the sales level that Lipitor was able to achieve but investors can still profit buying stock in companies developing drugs for patients with high cholesterol where Lipitor or other statins aren t enough to bring patients cholesterol levels
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company to Present at Needham Healthcare Conference,2017-03-30 20:30:00 +0000,http://finance.yahoo.com/news/medicines-company-present-needham-healthcare-203000605.html?.tsrc=rss,"The Medicines Company today announced that it will present at the 16th Annual Needham Healthcare Conference on Tuesday, April 4, 2017, at 8:00 a.m., Eastern daylight time."
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company to Present at Needham Healthcare Conference,2017-03-30 20:30:00 +0000,http://finance.yahoo.com/news/medicines-company-present-needham-healthcare-203000605.html,"[Business Wire] - The Medicines Company today announced that it will present at the 16th Annual Needham Healthcare Conference on Tuesday, April 4, 2017, at 8:00 a.m., Eastern daylight time."
MDCO,MDCO:UW,BBG000DX6TV8,The 3 Best Cholesterol Drug Stocks to Buy in 2017,2017-03-30 20:20:00 +0000,http://finance.yahoo.com/r/f11f721d-fa53-3132-97bb-9b627bd44756/the-3-best-cholesterol-drug-stocks-to-buy-in-2017.aspx?yptr=yahoo&.tsrc=rss,Investors should benefit from these biotechs' cholesterol drugs.
MDCO,MDCO:UW,BBG000DX6TV8,The 3 Best Cholesterol Drug Stocks to Buy in 2017,2017-03-30 20:20:00 +0000,https://www.fool.com/investing/2017/03/30/the-3-best-cholesterol-drug-stocks-to-buy-in-2017.aspx,The 3 Best Cholesterol Drug Stocks to Buy in 2017
MDCO,MDCO:UW,BBG000DX6TV8,"IJR, TCBI, WTFC, MDCO: Large Inflows Detected at ETF",2017-03-28 17:00:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jFxnwqvX5wg/ijr-tcbi-wtfc-mdco-large-inflows-detected-at-etf-cm766745,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Core S amp P Small Cap ETF Symbol IJR where we have detected an approximate 209 9 million dollar inflow that s a 0 7 increase week over week
MDCO,MDCO:UW,BBG000DX6TV8,"Sanofi Could Acquire This Biotech, But Is $1 Billion Too Low?",2017-03-24 20:19:53 +0000,http://www.investors.com/news/technology/sanofi-could-acquire-this-biotech-but-is-1-billion-too-low/?src=A00220A,"Sanofi Could Acquire This Biotech, But Is $1 Billion Too Low?"
MDCO,MDCO:UW,BBG000DX6TV8,"Regeneron, Sanofi Look To Crush Amgen, And Rivals Say They Can",2017-03-23 18:07:53 +0000,http://finance.yahoo.com/r/4a8d8ba0-9960-3f18-b9d3-ede454727461/regeneron-sanofi-look-to-crush-amgen-and-these-rivals-agree?src=A00220A&yptr=yahoo&.tsrc=rss,Regeneron expects to top Amgen's recent heart-drug study in a team-up with Sanofi.
MDCO,MDCO:UW,BBG000DX6TV8,"Regeneron, Sanofi Look To Crush Amgen, And Rivals Say They Can",2017-03-23 18:07:53 +0000,http://www.investors.com/news/technology/regeneron-sanofi-look-to-crush-amgen-and-these-rivals-agree/?src=A00220A,"Regeneron, Sanofi Look To Crush Amgen, And Rivals Say They Can"
MDCO,MDCO:UW,BBG000DX6TV8,How This Company Is Taking on Amgen,2017-03-23 15:02:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/o3sFnPtudZk/how-this-company-is-taking-on-amgen-cm764633,The Medicines Company NASDAQ MDCO recently announced positive phase 2 trial data for its cholesterol lowering drug inclisiran and if inclisiran can duplicate those results in a larger phase 3 study then it could end up challenging Amgen NASDAQ AMGN for market share
MDCO,MDCO:UW,BBG000DX6TV8,How This Company Is Taking on Amgen,2017-03-23 13:00:00 +0000,https://www.fool.com/investing/2017/03/23/how-this-company-wants-to-take-on-amgen.aspx,How This Company Is Taking on Amgen
MDCO,MDCO:UW,BBG000DX6TV8,How This Company Is Taking on Amgen,2017-03-23 13:00:00 +0000,http://finance.yahoo.com/r/bfe6c86d-aa3e-341b-b143-c15911488a1c/how-this-company-wants-to-take-on-amgen.aspx?yptr=yahoo&.tsrc=rss,The Medicines Company is developing a new drug that could give Amgen's Repatha a run for its money in lowering bad cholesterol levels.
MDCO,MDCO:UW,BBG000DX6TV8,Alnylam's LDL-Lowering Drug Positive in Phase II Study,2017-03-21 00:07:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TYYIozDtmz0/alnylams-ldl-lowering-drug-positive-in-phase-ii-study-cm763209,Alnylam Pharmaceuticals Inc ALNY and its partner The Medicines Company MDCO announced positive final results from the phase II study ORION 1 on their experimental PCSK9 inhibitor inclisiran which is being developed for the treatment of hypercholesterolemia Alnylam s share price
MDCO,MDCO:UW,BBG000DX6TV8,Alnylam's LDL-Lowering Drug Positive in Phase II Study,2017-03-20 22:11:10 +0000,http://finance.yahoo.com/news/alnylams-ldl-lowering-drug-positive-221110144.html,Alnylam's LDL-Lowering Drug Positive in Phase II Study
MDCO,MDCO:UW,BBG000DX6TV8,Alnylam's LDL-Lowering Drug Positive in Phase II Study,2017-03-20 22:11:10 +0000,http://finance.yahoo.com/news/alnylams-ldl-lowering-drug-positive-221110144.html?.tsrc=rss,"Alnylam Pharmaceuticals, Inc. (ALNY) and its partner The Medicines Company (MDCO) announced positive final results from the phase II study, ORION-1, on their experimental PCSK9 inhibitor, inclisiran."
MDCO,MDCO:UW,BBG000DX6TV8,Esperion And Medicines Co. Recover From Amgen-Induced Pitfall,2017-03-20 20:09:59 +0000,http://www.investors.com/news/technology/esperion-medicines-recover-from-amgen-induced-pitfall-on-trial-action/?src=A00220A,Esperion And Medicines Co. Recover From Amgen-Induced Pitfall
MDCO,MDCO:UW,BBG000DX6TV8,Esperion And Medicines Co. Recover From Amgen-Induced Pitfall,2017-03-20 20:09:59 +0000,http://finance.yahoo.com/r/79605871-198c-3800-b970-58b405bf14b4/esperion-medicines-recover-from-amgen-induced-pitfall-on-trial-action?src=A00220A&yptr=yahoo&.tsrc=rss,Esperion stock recovered from an Amgen-induced pitfall on Monday after the biotech outlined its path to FDA approval for a cholesterol drug.
MDCO,MDCO:UW,BBG000DX6TV8,Esperion Therapeutics Sees Clear FDA Path For Its Heart Drug,2017-03-20 11:32:00 +0000,http://www.forbes.com/sites/matthewherper/2017/03/20/is-esperion-therapeutics-going-to-benefit-from-a-trump-fda/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Esperion Therapeutics Sees Clear FDA Path For Its Heart Drug
MDCO,MDCO:UW,BBG000DX6TV8,"AMGN On Watch, GALE Reports Positive Data, EBS Secures BARDA Contract",2017-03-20 00:37:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qOd4UEe4AAo/amgn-on-watch-gale-reports-positive-data-ebs-secures-barda-contract-20170320-00009,"AMGN On Watch, GALE Reports Positive Data, EBS Secures BARDA Contract"
MDCO,MDCO:UW,BBG000DX6TV8,"12:16 pm The Medicines Co and Alnylam Pharmaceuticals (<a href=""/q?s=alny"" name=""alny"">ALNY</a>) announce positive final results from the ORION-1 Phase II study of inclisiran",2017-03-19 16:16:00 +0000,http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#mdco,"12:16 pm The Medicines Co and Alnylam Pharmaceuticals (<a href=""/q?s=alny"" name=""alny"">ALNY</a>) announce positive final results from the ORION-1 Phase II study of inclisiran"
MDCO,MDCO:UW,BBG000DX6TV8,"Amgen discounts cholesterol drug, but payers want more",2017-03-18 00:53:49 +0000,http://finance.yahoo.com/news/amgen-discounts-cholesterol-drug-payers-005349028.html?.tsrc=rss,"Amgen Inc sells its  cholesterol-lowering drug Repatha at a discount of about 30  percent to its U.S. list price of $14,000 a year, but the  largest pharmacy benefit managers say they want lower prices  after new data suggested more patients should be treated with  the drug.  Amgen, which on Friday presented data showing for the first  time that Repatha cuts the risk of heart attack and stroke  , said in a related presentation for investors that  it is netting between $7,700 to $11,200 per annual treatment  after discounts and rebates and believes those prices represent  good value.  Sean Harper, head of research and development at Amgen, told  Reuters that current industry discounts average 30 percent to 35  percent."
MDCO,MDCO:UW,BBG000DX6TV8,"How to Trade the Week's Most Active Stocks--Rite Aid, Amgen, MuleSoft and More",2017-03-17 23:15:00 +0000,http://finance.yahoo.com/r/b85c88ba-599e-3ef0-a1af-9163cfefc257/how-to-trade-the-week-s-most-active-stocks-rite-aid-amgen-mulesoft-and-more.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Here's how to trade six of the most active names on the market this past week.
MDCO,MDCO:UW,BBG000DX6TV8,"How to Trade the Week's Most Active Stocks--Rite Aid, Amgen, MuleSoft and More",2017-03-17 23:15:00 +0000,https://www.thestreet.com/story/14049955/1/how-to-trade-the-week-s-most-active-stocks-rite-aid-amgen-mulesoft-and-more.html?puc=yahoo&cm_ven=YAHOO,"How to Trade the Week's Most Active Stocks--Rite Aid, Amgen, MuleSoft and More"
MDCO,MDCO:UW,BBG000DX6TV8,"MEDICINES CO /DE Files SEC form 8-K, Other Events",2017-03-17 21:23:33 +0000,http://biz.yahoo.com/e/170317/mdco8-k.html,"MEDICINES CO /DE Files SEC form 8-K, Other Events"
MDCO,MDCO:UW,BBG000DX6TV8,The Biggest Loser: Amgen Drops 6.4%,2017-03-17 20:59:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/17/the-biggest-loser-amgen-drops-6-4/?mod=yahoobarrons&ru=yahoo,The Biggest Loser: Amgen Drops 6.4%
MDCO,MDCO:UW,BBG000DX6TV8,The Biggest Loser: Amgen Drops 6.4%,2017-03-17 20:59:00 +0000,http://finance.yahoo.com/r/6f0478d8-422b-3d5d-a479-40dc1e6b42c0/the-biggest-loser-amgen-drops-6-4?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,Shares of Amgen (AMGN) led the drop in the S&P 500 today falling almost 6.4% to close at $168.61 after the drug maker unveiled long-awaited data on its anti-cholesterol drug Repatha. Can shares of Amgen ...
MDCO,MDCO:UW,BBG000DX6TV8,Esperion's Dive On Amgen Heart Study 'Counterintuitive' On Pricing,2017-03-17 20:50:44 +0000,http://finance.yahoo.com/r/cbbf2454-c3d7-3898-95bd-300e302ced2c/esperion-dive-on-amgen-heart-study-counter-intuitive-on-pricing?src=A00220A&yptr=yahoo&.tsrc=rss,"The sell-off Friday on Esperion stock in light of Amgen's heart study results was unwarranted, an analyst said."
MDCO,MDCO:UW,BBG000DX6TV8,Esperion's Dive On Amgen Heart Study 'Counterintuitive' On Pricing,2017-03-17 20:50:44 +0000,http://www.investors.com/news/technology/esperion-dive-on-amgen-heart-study-counter-intuitive-on-pricing/?src=A00220A,Esperion's Dive On Amgen Heart Study 'Counterintuitive' On Pricing
MDCO,MDCO:UW,BBG000DX6TV8,Amgen Tanks On Heart Study; Shares Of Other Drugmakers Tumble,2017-03-17 20:28:27 +0000,http://finance.yahoo.com/r/87e82007-4089-3a7e-8ae8-d33f61eba73f/amgen-tanks-on-heart-study-shares-of-other-drugmakers-tumble?src=A00220A&yptr=yahoo&.tsrc=rss,Amgen stock crashed Friday after announcing its cholesterol drug Repatha didn't reduce the risk of cardiovascular death in a long-awaited study.
MDCO,MDCO:UW,BBG000DX6TV8,Amgen Tanks On Heart Study; Shares Of Other Drugmakers Tumble,2017-03-17 20:28:27 +0000,http://www.investors.com/news/technology/amgen-tanks-on-heart-study-shares-of-other-drugmakers-tumble/?src=A00220A,Amgen Tanks On Heart Study; Shares Of Other Drugmakers Tumble
MDCO,MDCO:UW,BBG000DX6TV8,"Here's Why Amgen, The Medicines Company, and Esperion Therapeutics Are All Tanking Today",2017-03-17 19:06:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Sr4bufeemDw/heres-why-amgen-the-medicines-company-and-esperion-therapeutics-are-all-tanking-today-cm762369,What happened Shares of Amgen NASDAQ AMGN 160 fell by more than 6 on Friday morning after the biotech giant reported clinical details from 160 its FOURIER study The trial was a long term cardiovascular outcomes study designed to compare Repatha Amgen s PCSK9
MDCO,MDCO:UW,BBG000DX6TV8,Alnylam touts latest trial data as suggesting its drugs are safe,2017-03-17 19:00:09 +0000,http://finance.yahoo.com/r/ae4d7dfb-a1b0-335a-b6ca-53d0d6661d63/alnylam-touts-latest-trial-data-as-suggesting-its.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Back in October, Alnylam Pharmaceuticals shelved its lead drug following the deaths of 19 patients in a late-stage trial, raising concerns among some investors that safety issues would plague the Cambridge firm’s entire pipeline.  The company has argued this isn’t the case.  Alnylam CEO John Maraganore said in a statement that the company was “delighted” with the data, which also showed that patients taking the drug experienced significant, long-lasting reductions in low-density lipoprotein cholesterol."
MDCO,MDCO:UW,BBG000DX6TV8,Alnylam touts latest trial data as suggesting its drugs are safe,2017-03-17 19:00:09 +0000,http://www.bizjournals.com/boston/news/2017/03/17/alnylam-touts-latest-trial-data-as-suggesting-its.html?ana=yahoo,Alnylam touts latest trial data as suggesting its drugs are safe
MDCO,MDCO:UW,BBG000DX6TV8,"Amgen, Esperion, AmTrust Financial and More: What is Going On With These Falling Stocks?",2017-03-17 18:56:58 +0000,http://finance.yahoo.com/r/95f52866-d2ff-36cc-b571-97b337737676/amgen-esperion-amtrust-financial-and-more-what-is-going-on-with-these-falling-stocks-567189?yptr=yahoo&.tsrc=rss,"Although all three major indexes have rebounded into the green this afternoon, shares of five companies, Amgen, Inc. (NASDAQ:AMGN), Esperion Therapeutics Inc (NASDAQ:ESPR), The Medicines Company (NASDAQ:MDCO), AmTrust Financial Services Inc (NASDAQ:AFSI), and Bank of America Corp (NYSE:BAC) are in the red. In this article, let’s find out what is causing each stock to fall and […]"
MDCO,MDCO:UW,BBG000DX6TV8,"Amgen, Esperion, AmTrust Financial and More: What is Going On With These Falling Stocks?",2017-03-17 18:56:58 +0000,http://www.insidermonkey.com/blog/amgen-esperion-amtrust-financial-and-more-what-is-going-on-with-these-falling-stocks-567189/,"Amgen, Esperion, AmTrust Financial and More: What is Going On With These Falling Stocks?"
MDCO,MDCO:UW,BBG000DX6TV8,Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher,2017-03-17 17:21:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VNv-e-UkTfQ/mid-day-market-update-us-stocks-turn-negative-avexis-shares-spike-higher-cm762348,Midway through trading Friday the Dow traded down 0 04 percent to 20 926 33 while the NASDAQ declined 0 12 percent to 5 893 72 The S amp P also fell dropping 0 07 percent to 2 379 73 Leading and Lagging Sectors Non cyclical consumer goods amp services shares climbed 0 53
MDCO,MDCO:UW,BBG000DX6TV8,"Amgen Blew It…For Medicines Co., Esperion Too",2017-03-17 17:03:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/17/amgen-blew-it-for-medicines-co-esperion-too/?mod=yahoobarrons&ru=yahoo,"Amgen Blew It…For Medicines Co., Esperion Too"
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company and Alnylam Pharmaceuticals Report Positive Final Results from ORION-1 Phase II Study of Inclisiran,2017-03-17 16:15:00 +0000,http://finance.yahoo.com/news/medicines-company-alnylam-pharmaceuticals-report-161500446.html,"[Business Wire] - The Medicines Company and Alnylam Pharmaceuticals, Inc. today announced positive final results from the ORION-1 Phase II study of inclisiran, an investigational, first-in-class PCSK9 synthesis inhibitor being developed for the treatment of hypercholesterolemia."
MDCO,MDCO:UW,BBG000DX6TV8,Mid-Morning Market Update: Markets Edge Higher; Tiffany Earnings Top Estimates,2017-03-17 15:21:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/87f2TufHB8g/mid-morning-market-update-markets-edge-higher-tiffany-earnings-top-estimates-cm762287,Following the market opening Friday the Dow traded up 0 07 percent to 20 950 20 while the NASDAQ gained 0 01 percent to 5 901 52 The S amp P also rose gaining 0 04 percent to 2 382 30 Leading and Lagging Sectors Basic materials shares climbed 0 56 percent in trading on
MDCO,MDCO:UW,BBG000DX6TV8,"[video]AveXis, Esperion and Amgen Among Biotech Movers",2017-03-17 15:03:00 +0000,https://www.thestreet.com/story/14049078/1/avexis-esperion-and-amgen-among-biotech-movers.html?puc=yahoo&cm_ven=YAHOO,"[video]AveXis, Esperion and Amgen Among Biotech Movers"
MDCO,MDCO:UW,BBG000DX6TV8,Amgen Could Boost Rivals On Positive Heart-Disease Study: Analyst,2017-03-14 20:06:46 +0000,http://www.investors.com/news/technology/amgen-could-haul-up-these-rivals-if-heart-disease-study-tops-analyst/?src=A00220A,Amgen Could Boost Rivals On Positive Heart-Disease Study: Analyst
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company to Webcast Presentation of ORION-1 Phase II Study of Inclisiran at ACC.17,2017-03-14 11:00:00 +0000,http://finance.yahoo.com/news/medicines-company-webcast-presentation-orion-110000312.html,"[Business Wire] - The Medicines Company today announced that it will webcast, over the internet simultaneously with the presentation, the detailed results from its ORION-1 Phase II study of inclisiran, the Company’s PCSK9 synthesis inhibitor, featured in the “Late-Breaking Clinical Trials - Featured Clinical Research 1” session at the American College of Cardiology’s 66th Annual Scientific Session on Friday, March 17, ..."
MDCO,MDCO:UW,BBG000DX6TV8,"Notable Friday Option Activity: ILG, MDCO, MTN",2017-03-11 00:12:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/y8MvAymKrRo/notable-friday-option-activity-ilg-mdco-mtn-cm759360,Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in ILG Inc Symbol ILG where a total of 11 176 contracts have traded so far representing approximately 1 1 million underlying shares That amounts to about 130 of ILG s average
MDCO,MDCO:UW,BBG000DX6TV8,MEDICINES CO /DE Financials,2017-03-07 18:04:15 +0000,http://finance.yahoo.com/q/is?s=mdco,MEDICINES CO /DE Financials
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company to Host Conference Call and Webcast at Upcoming American College of Cardiology’s 66th Annual Scientific Sessions,2017-03-06 12:00:00 +0000,http://finance.yahoo.com/news/medicines-company-host-conference-call-120000695.html,"[Business Wire] - The Medicines Company will host a conference call and webcast on Friday, March 17, 2017, at 3:30 p.m., Eastern Time, to review data from the ORION-1 Phase II study of inclisiran, the Company’s PCSK9 synthesis inhibitor."
MDCO,MDCO:UW,BBG000DX6TV8,"The Medicines Co. :MDCO-US: Earnings Analysis: 2016 By the Numbers : March 2, 2017",2017-03-02 17:06:17 +0000,http://www.capitalcube.com/blog/index.php/the-medicines-co-mdco-us-earnings-analysis-2016-by-the-numbers-march-2-2017/,"The Medicines Co. :MDCO-US: Earnings Analysis: 2016 By the Numbers : March 2, 2017"
MDCO,MDCO:UW,BBG000DX6TV8,Medicines Company (MDCO) Q4 Loss Narrower than Expected,2017-03-01 17:15:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZhCq7UQ8uyc/medicines-company-mdco-q4-loss-narrower-than-expected-cm754907,The Medicines Company MDCO reported a loss of 1 29 per share including the impact of share based compensation expenses in the fourth quarter of 2016 narrower than Zacks Consensus Estimate of a loss of 1 43 The quarterly loss however widened from the year ago loss of 95 cents per
MDCO,MDCO:UW,BBG000DX6TV8,Medicines Company (MDCO) Q4 Loss Narrower than Expected,2017-03-01 14:37:02 +0000,http://finance.yahoo.com/news/medicines-company-mdco-q4-loss-143702497.html,Medicines Company (MDCO) Q4 Loss Narrower than Expected
MDCO,MDCO:UW,BBG000DX6TV8,"The Medicines Co. :MDCO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 1, 2017",2017-03-01 14:29:29 +0000,http://www.capitalcube.com/blog/index.php/the-medicines-co-mdco-us-earnings-analysis-q4-2016-by-the-numbers-march-1-2017/,"The Medicines Co. :MDCO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 1, 2017"
MDCO,MDCO:UW,BBG000DX6TV8,"MEDICINES CO /DE Files SEC form 10-K, Annual Report",2017-03-01 11:09:43 +0000,http://biz.yahoo.com/e/170301/mdco10-k.html,"MEDICINES CO /DE Files SEC form 10-K, Annual Report"
MDCO,MDCO:UW,BBG000DX6TV8,"Better Buy: bluebird bio, Inc. vs. Alnylam Pharmaceuticals",2017-02-28 20:51:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DhyPAbFdy0U/better-buy-bluebird-bio-inc-vs-alnylam-pharmaceuticals-cm754355,In this edition of our ongoing Better Buy series we ve got two biotechs trading well off their highs bluebird bio NASDAQ BLUE peaked in the middle of 2015 when it appeared that the company s gene therapy was able to cure sickle cell anemia patients Subsequent patients didn
MDCO,MDCO:UW,BBG000DX6TV8,Edited Transcript of MDCO earnings conference call or presentation 28-Feb-17 1:30pm GMT,2017-02-28 19:45:52 +0000,http://finance.yahoo.com/news/edited-transcript-mdco-earnings-conference-194552629.html,Edited Transcript of MDCO earnings conference call or presentation 28-Feb-17 1:30pm GMT
MDCO,MDCO:UW,BBG000DX6TV8,Medicines Co. reports 4Q loss,2017-02-28 12:25:40 +0000,http://sg.finance.yahoo.com/news/medicines-co-reports-4q-loss-122540996.html,Medicines Co. reports 4Q loss
MDCO,MDCO:UW,BBG000DX6TV8,Q4 2016 Medicines Co Earnings Release - Before Market Open,2017-02-28 12:07:03 +0000,http://biz.yahoo.com/research/earncal/20170228.html?t=mdco,Q4 2016 Medicines Co Earnings Release - Before Market Open
MDCO,MDCO:UW,BBG000DX6TV8,"MEDICINES CO /DE Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits",2017-02-28 12:04:30 +0000,http://biz.yahoo.com/e/170228/mdco8-k.html,"MEDICINES CO /DE Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits"
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company Reports Fourth-Quarter and Full-Year 2016 Financial Results,2017-02-28 12:00:00 +0000,http://finance.yahoo.com/news/medicines-company-reports-fourth-quarter-120000135.html,"[Business Wire] - The Medicines Company today announced its financial results for the fourth-quarter and full-year ended December 31, 2016."
MDCO,MDCO:UW,BBG000DX6TV8,"Earnings Reaction History: The Medicines Company, 44.4% Follow-Through Indicator, 4.2% Sensitive",2017-02-28 11:49:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KoPoNfYmWjA/earnings-reaction-history-the-medicines-company-444-follow-through-indicator-42-sensitive-cm753965,Expected Earnings Release 02 28 2017 PremarketExpected Earnings Release 02 28 2017 Premarket Avg Extended Hours Dollar Volume 166 108Avg Extended Hours Dollar Volume 166 108 The Medicines Company MDCO is due to issue its quarterly earnings report in the upcoming extended
MDCO,MDCO:UW,BBG000DX6TV8,"Pre-Market Earnings Report for February 28, 2017 :  BNS, BMO, TGT, SRE, CNP, LNG, DPZ, VRX, NRG, IONS, PDCE, MDCO",2017-02-27 21:19:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-1zyMJFWwGY/pre-market-earnings-report-for-february-28-2017-bns-bmo-tgt-sre-cnp-lng-dpz-vrx-nrg-ions-pdce-mdco-cm753829,The following companies are expected to report earnings prior to market open on 02 28 2017 Visit our Earnings Calendar for a full list of expected earnings releases Bank of Nova Scotia BNS is reporting for the quarter ending January 31 2017 The
MDCO,MDCO:UW,BBG000DX6TV8,"Notable ETF Outflow Detected - PJP, MDCO, AGN, PBH",2017-02-22 17:52:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HcGA2CcVH0M/notable-etf-outflow-detected-pjp-mdco-agn-pbh-cm751422,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the PowerShares Dynamic Pharmaceuticals Portfolio Symbol PJP where we have detected an approximate 18 3 million dollar outflow that s a 2 1 decrease week over
MDCO,MDCO:UW,BBG000DX6TV8,"Biotech Stock Roundup: Alexion Reports 4Q Results, Celgene MS Drug Looks Promising",2017-02-22 14:11:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lvmQma1GC9s/biotech-stock-roundup-alexion-reports-4q-results-celgene-ms-drug-looks-promising-cm751060,Key updates in the biotech sector include a mixed quarter from Alexion ALXN and promising data on Celgene s CELG investigational multiple sclerosis MS treatment Recap of the Week s Most Important Stories Mixed Results from Alexion Alexion s fourth quarter results were mixed
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company Announces FDA Filing Acceptance of New Drug Application for Intravenous Antibiotic Carbavance® (meropenem-vaborbactam),2017-02-21 12:15:00 +0000,http://finance.yahoo.com/news/medicines-company-announces-fda-filing-121500361.html,[Business Wire] - The Medicines Company today announced that the U.S. Food and Drug Administration has accepted for priority review the Company’s new drug application filing for Carbavance® for the treatment of complicated urinary tract infections .
MDCO,MDCO:UW,BBG000DX6TV8,"Boxer Capital, LLC Buys AveXis, BeiGene, Alnylam Pharmaceuticals, Sells Biomarin ...",2017-02-17 20:51:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XwYgiiI0jBI/boxer-capital-llc-buys-avexis-beigene-alnylam-pharmaceuticals-sells-biomarin-cm749825,Boxer Capital LLC New Purchases ALNY ALXN SBBP SNSS BLPH RXDX Added Positions AVXS BGNE MDCO Reduced Positions SGEN CLVS ARDM Sold Out BMRN RIGL HRTX EBIO EPIX New Purchases ALNY ALXN SBBP SNSS BLPH RXDX
MDCO,MDCO:UW,BBG000DX6TV8,"The Medicines Company to Announce Fourth-Quarter and Full-Year 2016 Financial Results on February 28, 2017",2017-02-17 12:00:00 +0000,http://finance.yahoo.com/news/medicines-company-announce-fourth-quarter-120000386.html,"[Business Wire] - The Medicines Company will host a conference call on Tuesday, February 28, 2017, at 8:30 a.m., Eastern Time, to discuss fourth-quarter and full-year 2016 financial results and operational developments."
MDCO,MDCO:UW,BBG000DX6TV8,"Biotech Premarket Movers: Ardelyx, Acorda Therapeutics, Medicines Co.",2017-02-15 14:27:00 +0000,https://www.thestreet.com/story/14003282/1/biotech-premarket-movers-ardelyx-acorda-therapeutics-medicines-co.html?puc=yahoo&cm_ven=YAHOO,"Biotech Premarket Movers: Ardelyx, Acorda Therapeutics, Medicines Co."
MDCO,MDCO:UW,BBG000DX6TV8,"Alnylam Pharmaceuticals, Inc. Presents Progress -- Investors Dig It",2017-02-09 22:19:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LbVpeB5PeXA/alnylam-pharmaceuticals-inc-presents-progress-investors-dig-it-cm745852,Alnylam Pharmaceuticals NASDAQ ALNY jumped as much as 14 5 today after announcing earnings after the bell yesterday As a development stage biotech it wasn t the revenue or the earnings that caused the spike but the progression of Allnylam s pipeline Nevertheless here s how
MDCO,MDCO:UW,BBG000DX6TV8,"Alnylam Pharmaceuticals, Inc. Presents Progress -- Investors Dig It",2017-02-09 20:34:12 +0000,http://www.fool.com/investing/2017/02/09/alnylam-pharmaceuticals-inc-presents-progress-inve.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Alnylam Pharmaceuticals, Inc. Presents Progress -- Investors Dig It"
MDCO,MDCO:UW,BBG000DX6TV8,"Alnylam (ALNY) Q3 Loss Narrower than Expected, Revenues Rise",2017-02-09 18:18:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-yl-3XNw52s/alnylam-alny-q3-loss-narrower-than-expected-revenues-rise-cm745649,Alnylam Pharmaceuticals Inc ALNY reported a loss of 1 32 per share in the fourth quarter of 2016 narrower than both the Zacks Consensus Estimate loss of 1 35 and the year ago loss of 1 07 Quarterly revenues rose 131 1 to 17 5 million Additionally revenues were also above the
MDCO,MDCO:UW,BBG000DX6TV8,"Alnylam (ALNY) Q3 Loss Narrower than Expected, Revenues Rise",2017-02-09 16:07:04 +0000,http://finance.yahoo.com/news/alnylam-alny-q3-loss-narrower-160704608.html,"Alnylam (ALNY) Q3 Loss Narrower than Expected, Revenues Rise"
MDCO,MDCO:UW,BBG000DX6TV8,"ESPR, MDCO Riding High, New Uses For MRK's Old Drug, DBVT In Full Smile(e)",2017-02-06 00:43:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EOS3Jpb0UZU/espr-mdco-riding-high-new-uses-for-mrks-old-drug-dbvt-in-full-smilee-20170206-00016,"ESPR, MDCO Riding High, New Uses For MRK's Old Drug, DBVT In Full Smile(e)"
MDCO,MDCO:UW,BBG000DX6TV8,Why The Medicines Company Rocketed Higher Today,2017-02-04 00:04:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aFu6Rcegt4E/why-the-medicines-company-rocketed-higher-today-cm743169,Image source Getty Images What happened The Medicines Company NASDAQ MDCO shot up 21 today after competitor Amgen NASDAQ AMGN announced data from its FOURIER clinical trial Amgen s PCSK9 inhibitor Repatha significantly reduced the risk of cardiovascular
MDCO,MDCO:UW,BBG000DX6TV8,Why The Medicines Company Rocketed Higher Today,2017-02-03 21:32:59 +0000,http://www.fool.com/investing/2017/02/03/why-the-medicines-company-rocketed-higher-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why The Medicines Company Rocketed Higher Today
MDCO,MDCO:UW,BBG000DX6TV8,"Amgen's LDL-Buster Boosts The Medicines Co., But Regeneron Slides",2017-02-03 21:24:34 +0000,http://www.investors.com/news/technology/amgens-ldl-buster-ramps-the-medicines-co-but-regeneron-slides/,"Amgen's LDL-Buster Boosts The Medicines Co., But Regeneron Slides"
MDCO,MDCO:UW,BBG000DX6TV8,Amgen CEO: Will work with Trump to lower drug prices,2017-02-02 22:49:00 +0000,http://finance.yahoo.com/video/amgen-ceo-trump-lower-drug-224900304.html,Amgen CEO: Will work with Trump to lower drug prices
MDCO,MDCO:UW,BBG000DX6TV8,Mallinckrodt (MNK) Earnings This Quarter: Stock to Disappoint?,2017-02-01 21:30:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BlJhQrVQ56E/mallinckrodt-mnk-earnings-this-quarter-stock-to-disappoint-cm741800,Mallinckrodt plc MNK is set to report results for the quarter ended Dec 30 2016 on Feb 7 We note that this quarter is a transition quarter for the company In May 2016 Mallinckrodt announced that its board of directors has approved a change in the company s fiscal year end to the last
MDCO,MDCO:UW,BBG000DX6TV8,Insiders Buy the Holdings of FTXH ETF,2017-01-25 16:34:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/glaw6FLHRWY/insiders-buy-the-holdings-of-ftxh-etf-cm737979,A look at the weighted underlying holdings of the First Trust Nasdaq Pharmaceuticals ETF Symbol FTXH shows an impressive 14 9 of holdings on a weighted basis have experienced insider buying within the past six months Medicines Co Symbol MDCO which makes up 2 20 of the First
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company to Present Results from ORION-1 Phase 2 Study of Inclisiran at the American College of Cardiology’s 66th Annual Scientific Session,2017-01-25 12:00:00 +0000,http://finance.yahoo.com/news/medicines-company-present-results-orion-120000022.html,"[Business Wire] - The Medicines Company today announced that full safety and efficacy data from the ORION-1 Phase 2 study of inclisiran, with six- to nine-month follow-up for all patients in the study, will be presented at the American College of Cardiology's 66th Annual Scientific Session , to be held March 17-19, 2017, in Washington D.C."
MDCO,MDCO:UW,BBG000DX6TV8,Theravance's Infection Drug Vibativ Positive in TOUR Study,2017-01-24 16:34:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uVToTbc8y3c/theravances-infection-drug-vibativ-positive-in-tour-study-cm737307,Theravance Biopharma Inc TBPH recently released positive interim data from the ongoing TOUR Telavancin Observational Use Registry study evaluating how Vibativ telavancin is used to treat patients with bacteremia or infective endocarditis IE We note that Vibativ is the only
MDCO,MDCO:UW,BBG000DX6TV8,"The Medicines Co. breached its 50 day moving average in a Bearish Manner : MDCO-US : January 23, 2017",2017-01-23 13:27:11 +0000,http://www.capitalcube.com/blog/index.php/the-medicines-co-breached-its-50-day-moving-average-in-a-bearish-manner-mdco-us-january-23-2017/,"The Medicines Co. breached its 50 day moving average in a Bearish Manner : MDCO-US : January 23, 2017"
MDCO,MDCO:UW,BBG000DX6TV8,"Noteworthy Friday Option Activity: MDCO, BYD, WLK",2017-01-20 21:38:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0lli_htcu2Q/noteworthy-friday-option-activity-mdco-byd-wlk-cm736219,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Medicines Co Symbol MDCO where a total volume of 4 736 contracts has been traded thus far today a contract volume which is representative of approximately 473 600
MDCO,MDCO:UW,BBG000DX6TV8,"ETFs with exposure to The Medicines Co. : January 20, 2017",2017-01-20 18:32:43 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-the-medicines-co-january-20-2017/,"ETFs with exposure to The Medicines Co. : January 20, 2017"
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Co LDL-Lowering Drug Positive in Phase II,2017-01-09 14:52:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OcJ2DNAj_Is/the-medicines-co-ldl-lowering-drug-positive-in-phase-ii-cm731030,The Medicines Company MDCO announced positive top line results from a Day 180 interim analysis of the ongoing ORION 1 phase II study on its pipeline candidate Inclisiran formerly PCSK9si for the treatment of hypercholesterolemia The Medicines Company is developing Inclisiran under
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Co LDL-Lowering Drug Positive in Phase II,2017-01-09 13:12:01 +0000,http://finance.yahoo.com/news/medicines-co-ldl-lowering-drug-131201805.html,The Medicines Co LDL-Lowering Drug Positive in Phase II
MDCO,MDCO:UW,BBG000DX6TV8,"The Medicines Company Announces Positive Top-Line Results from Day 180 Interim Analysis in Ongoing ORION-1 Phase 2 Study of Inclisiran (formerly, PCSK9si)",2017-01-08 23:00:00 +0000,http://finance.yahoo.com/news/medicines-company-announces-positive-top-230000816.html,"[Business Wire] - The Medicines Company today announced positive top-line results from the interim analysis with Day 180 follow-up for all 501 patients enrolled in the ongoing ORION-1 Phase 2 study of inclisiran, its investigational, first-in-class PCSK9 synthesis inhibitor."
MDCO,MDCO:UW,BBG000DX6TV8,"EXAS Abuzz, MACK Makes Deal With Ipsen, XENE Awaits Data",2017-01-08 22:22:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WoouSJVRzBk/exas-abuzz-mack-makes-deal-with-ipsen-xene-awaits-data-20170108-00044,"EXAS Abuzz, MACK Makes Deal With Ipsen, XENE Awaits Data"
MDCO,MDCO:UW,BBG000DX6TV8,Could Sanofi Acquire BioMarin In Wake Of Amgen LDL Brouhaha?,2017-01-06 21:22:41 +0000,http://www.investors.com/news/technology/could-sanofi-acquire-biomarin-in-wake-of-amgen-ldl-brouhaha/,Could Sanofi Acquire BioMarin In Wake Of Amgen LDL Brouhaha?
MDCO,MDCO:UW,BBG000DX6TV8,"[video]Amgen Shares Skyrocket on Surprise Patent Victory, Plus Jim Cramer's View",2017-01-06 15:13:00 +0000,https://www.thestreet.com/story/13945136/1/amgen-shares-skyrocket-on-surprise-patent-victory.html?puc=yahoo&cm_ven=YAHOO,"[video]Amgen Shares Skyrocket on Surprise Patent Victory, Plus Jim Cramer's View"
MDCO,MDCO:UW,BBG000DX6TV8,"Health Care Sector Update for 01/06/2017: MDCO, SNY, REGN, JNJ, PFE, ABT, MRK, AMGN",2017-01-06 14:37:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-FSw4rzCJ-4/health-care-sector-update-for-01062017-mdco-sny-regn-jnj-pfe-abt-mrk-amgn-cm730266,Top Health Care stocks Top Health Care stocks JNJ 0 1 JNJ 0 1 PFE flatPFE flat ABT 0 3 ABT 0 3 MRK flatMRK flat AMGN 4 6 AMGN 4 6 Health care shares were mixed in pre market trade Friday Health care shares were mixed in pre market trade Friday In health care stocks
MDCO,MDCO:UW,BBG000DX6TV8,These 5 Biotech Stocks Could Be Big Takeover Targets in 2017,2017-01-06 13:35:11 +0000,http://finance.yahoo.com/news/5-biotech-stocks-could-big-133511110.html,These 5 Biotech Stocks Could Be Big Takeover Targets in 2017
MDCO,MDCO:UW,BBG000DX6TV8,"The Medicines Co. breached its 50 day moving average in a Bullish Manner : MDCO-US : January 5, 2017",2017-01-05 13:18:07 +0000,http://www.capitalcube.com/blog/index.php/the-medicines-co-breached-its-50-day-moving-average-in-a-bullish-manner-mdco-us-january-5-2017/,"The Medicines Co. breached its 50 day moving average in a Bullish Manner : MDCO-US : January 5, 2017"
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company to Present at J. P. Morgan Healthcare Conference,2017-01-04 21:30:00 +0000,http://finance.yahoo.com/news/medicines-company-present-j-p-213000085.html,"[Business Wire] - The Medicines Company today announced that its Chief Executive Officer, Clive Meanwell, M.D., Ph.D., will present at the 35th Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2017, at 7:30 a.m., Pacific time."
MDCO,MDCO:UW,BBG000DX6TV8,[$$] London-based regulator for EU drugs fears staff exodus,2017-01-03 11:05:16 +0000,"http://www.ft.com/cms/s/2ca416ba-c8f8-11e6-8f29-9445cac8966f,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev",[at Financial Times] - The head of the EU's London-based drugs regulator says the agency has lost an unprecedented number of senior staff since the Brexit vote and warns that as many as half could walk out unless its future ...
MDCO,MDCO:UW,BBG000DX6TV8,"The Medicines Co. breached its 50 day moving average in a Bearish Manner : MDCO-US : December 23, 2016",2016-12-23 12:40:51 +0000,http://www.capitalcube.com/blog/index.php/the-medicines-co-breached-its-50-day-moving-average-in-a-bearish-manner-mdco-us-december-23-2016/,"The Medicines Co. breached its 50 day moving average in a Bearish Manner : MDCO-US : December 23, 2016"
MDCO,MDCO:UW,BBG000DX6TV8,MDCO Crosses Below Key Moving Average Level,2016-12-21 22:56:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eki5RTNw2Js/mdco-crosses-below-key-moving-average-level-cm724836,In trading on Wednesday shares of Medicines Co Symbol MDCO crossed below their 200 day moving average of 35 82 changing hands as low as 35 52 per share Medicines Co shares are currently trading off about 2 1 on the day The chart below shows the one year performance of MDCO shares
MDCO,MDCO:UW,BBG000DX6TV8,Interesting MDCO Put And Call Options For February 2017,2016-12-21 16:57:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pYjOAVQ_Ck0/interesting-mdco-put-and-call-options-for-february-2017-cm724569,Investors in Medicines Co Symbol MDCO saw new options become available this week for the February 2017 expiration At Stock Options Channel our YieldBoost formula has looked up and down the MDCO options chain for the new February 2017 contracts and identified one put and one call contract
MDCO,MDCO:UW,BBG000DX6TV8,"Insider Buying Volume Big as Trump Rally Rolls On: Transdigm, Medicines Company, Medley Capital, W&T Offshore and More",2016-12-18 15:10:14 +0000,http://247wallst.com/investing/2016/12/18/insider-buying-volume-big-as-trump-rally-rolls-on-transdigm-medicines-company-medley-capital-wt-offshore-and-more/,"Insider Buying Volume Big as Trump Rally Rolls On: Transdigm, Medicines Company, Medley Capital, W&T Offshore and More"
MDCO,MDCO:UW,BBG000DX6TV8,Alnylam Pharma Announces Its Initial 2017 Pipeline Goals - Quick Facts,2016-12-16 07:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YcOFFnw4tH4/alnylam-pharma-announces-its-initial-2017-pipeline-goals--quick-facts-20161216-00166,Alnylam Pharma Announces Its Initial 2017 Pipeline Goals - Quick Facts
MDCO,MDCO:UW,BBG000DX6TV8,First Trust Nasdaq Pharmaceuticals ETF -- Insider Buying Index Registering 10.7%,2016-12-14 15:59:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ufiTJ2wP3j4/first-trust-nasdaq-pharmaceuticals-etf-insider-buying-index-registering-107-cm721254,A look at the weighted underlying holdings of the First Trust Nasdaq Pharmaceuticals ETF Symbol FTXH shows an impressive 10 7 of holdings on a weighted basis have experienced insider buying within the past six months Abbott Laboratories Symbol ABT which makes up 8 43 of the
MDCO,MDCO:UW,BBG000DX6TV8,"The Medicines Co. – Value Analysis (NASDAQ:MDCO) : December 14, 2016",2016-12-14 15:57:23 +0000,http://www.capitalcube.com/blog/index.php/the-medicines-co-value-analysis-nasdaqmdco-december-14-2016/,"The Medicines Co. – Value Analysis (NASDAQ:MDCO) : December 14, 2016"
MDCO,MDCO:UW,BBG000DX6TV8,"The Medicines Co. breached its 50 day moving average in a Bullish Manner : MDCO-US : December 13, 2016",2016-12-13 12:14:45 +0000,http://www.capitalcube.com/blog/index.php/the-medicines-co-breached-its-50-day-moving-average-in-a-bullish-manner-mdco-us-december-13-2016/,"The Medicines Co. breached its 50 day moving average in a Bullish Manner : MDCO-US : December 13, 2016"
MDCO,MDCO:UW,BBG000DX6TV8,6 Stocks Traded by Insiders Last Week,2016-12-12 18:06:55 +0000,http://finance.yahoo.com/news/6-stocks-traded-insiders-last-180655457.html,6 Stocks Traded by Insiders Last Week
MDCO,MDCO:UW,BBG000DX6TV8,"Insider Buying Stays Red-Hot as Trump Rally Rolls On: Wendy’s, Medicines Company, Transdigm and More",2016-12-11 15:20:48 +0000,http://247wallst.com/investing/2016/12/11/insider-buying-stays-red-hot-as-trump-rally-rolls-on-wendys-medicines-company-transdigm-and-more/,"Insider Buying Stays Red-Hot as Trump Rally Rolls On: Wendy’s, Medicines Company, Transdigm and More"
MDCO,MDCO:UW,BBG000DX6TV8,"Friday's ETF Movers: PJP, GDXJ",2016-12-09 19:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KF1_0mrMkuA/fridays-etf-movers-pjp-gdxj-cm719512,In trading on Friday the PowerShares Dynamic Pharmaceuticals Portfolio ETF PJP is outperforming other ETFs up about 1 5 on the day Components of that ETF showing particular strength include shares of The Medicines MDCO up about 5 6 and shares of Bristol Myers Squibb BMY
MDCO,MDCO:UW,BBG000DX6TV8,"Friday 12/9 Insider Buying Report: MDCO, ZYNE",2016-12-09 16:58:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/f6mCxC_6Dfs/friday-129-insider-buying-report-mdco-zyne-cm719326,As the saying goes there are many possible reasons for an insider to sell a stock but only one reason to buy they expect to make money So let s look at two noteworthy recent insider buys On Thursday Medicines MDCO s Director Fredric N Eshelman made a 20 99M purchase of
MDCO,MDCO:UW,BBG000DX6TV8,Coverage initiated on The Medicines Co by H.C. Wainwright,2016-12-05 12:13:43 +0000,http://finance.yahoo.com/q/ud?s=MDCO,Coverage initiated on The Medicines Co by H.C. Wainwright
MDCO,MDCO:UW,BBG000DX6TV8,Is Lexmark International Inc (LXK) A Good Stock To Buy Right Now?,2016-12-05 01:54:03 +0000,http://www.insidermonkey.com/blog/is-lexmark-international-inc-lxk-a-good-stock-to-buy-right-now-493008/,Is Lexmark International Inc (LXK) A Good Stock To Buy Right Now?
MDCO,MDCO:UW,BBG000DX6TV8,Hedge Funds Are Betting On The Medicines Company (MDCO),2016-12-02 16:13:25 +0000,http://www.insidermonkey.com/blog/hedge-funds-are-betting-on-the-medicines-company-mdco-492760/,Hedge Funds Are Betting On The Medicines Company (MDCO)
MDCO,MDCO:UW,BBG000DX6TV8,"Biotechs Aerie, Medicines Co., Tesaro Could Rocket, Or Be Bought: RBC",2016-12-01 21:52:32 +0000,http://www.investors.com/news/technology/biotechs-aerie-regeneron-tesaro-could-rocket-or-become-ma-fodder/,"Biotechs Aerie, Medicines Co., Tesaro Could Rocket, Or Be Bought: RBC"
MDCO,MDCO:UW,BBG000DX6TV8,"ETFs with exposure to The Medicines Co. : November 30, 2016",2016-11-30 17:35:12 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-the-medicines-co-november-30-2016/,"ETFs with exposure to The Medicines Co. : November 30, 2016"
MDCO,MDCO:UW,BBG000DX6TV8,MDCO Crosses Below Key Moving Average Level,2016-11-29 17:52:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PbsjdHo2b7s/mdco-crosses-below-key-moving-average-level-cm715179,In trading on Tuesday shares of Medicines Co Symbol MDCO crossed below their 200 day moving average of 35 65 changing hands as low as 34 81 per share Medicines Co shares are currently trading down about 1 3 on the day The chart below shows the one year performance of MDCO shares
MDCO,MDCO:UW,BBG000DX6TV8,"The Medicines Co. breached its 50 day moving average in a Bearish Manner : MDCO-US : November 29, 2016",2016-11-29 12:28:28 +0000,http://www.capitalcube.com/blog/index.php/the-medicines-co-breached-its-50-day-moving-average-in-a-bearish-manner-mdco-us-november-29-2016/,"The Medicines Co. breached its 50 day moving average in a Bearish Manner : MDCO-US : November 29, 2016"
MDCO,MDCO:UW,BBG000DX6TV8,Movers In Biotech: Cellectar Biosciences Inc (CLRB) And The Medicines Company (MDCO),2016-11-17 15:11:17 +0000,http://www.insidermonkey.com/blog/movers-in-biotech-cellectar-biosciences-inc-clrb-and-the-medicines-company-mdco-488574/,Movers In Biotech: Cellectar Biosciences Inc (CLRB) And The Medicines Company (MDCO)
MDCO,MDCO:UW,BBG000DX6TV8,"Medicines Co., Alnylam Split On Amgen-Rivaling Cholesterol-Buster",2016-11-16 21:29:02 +0000,http://www.investors.com/news/technology/medicines-co-alnylam-split-on-amgen-rivaling-cholesterol-buster/,"Medicines Co., Alnylam Split On Amgen-Rivaling Cholesterol-Buster"
MDCO,MDCO:UW,BBG000DX6TV8,"Biotech Stock Roundup: Biotech Stocks Soar on Election Results, Gilead HBV Drug Approved",2016-11-16 14:52:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H6n1m2qsSWo/biotech-stock-roundup-biotech-stocks-soar-on-election-results-gilead-hbv-drug-approved-cm710023,Earnings reports pipeline updates and regulatory news were overshadowed by the run up to the Presidential election and the surprise win of Donald Trump In fact the biotech sector responded favorably to Trump s victory on hopes that there will be fewer drug pricing headwinds considering Trump
MDCO,MDCO:UW,BBG000DX6TV8,"Biotech Stock Roundup: Biotech Stocks Soar on Election Results, Gilead HBV Drug Approved",2016-11-16 13:12:01 +0000,http://finance.yahoo.com/news/biotech-stock-roundup-biotech-stocks-131201850.html,"Biotech Stock Roundup: Biotech Stocks Soar on Election Results, Gilead HBV Drug Approved"
MDCO,MDCO:UW,BBG000DX6TV8,"The Medicines Co. breached its 50 day moving average in a Bullish Manner : MDCO-US : November 16, 2016",2016-11-16 12:20:19 +0000,http://www.capitalcube.com/blog/index.php/the-medicines-co-breached-its-50-day-moving-average-in-a-bullish-manner-mdco-us-november-16-2016/,"The Medicines Co. breached its 50 day moving average in a Bullish Manner : MDCO-US : November 16, 2016"
MDCO,MDCO:UW,BBG000DX6TV8,Long-lasting cholesterol lowering seen with Medicines Co drug - study,2016-11-15 17:57:04 +0000,http://in.finance.yahoo.com/news/long-lasting-cholesterol-lowering-seen-175704649.html,Long-lasting cholesterol lowering seen with Medicines Co drug - study
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company and Alnylam Pharmaceuticals Present Positive Results from ORION-1 Phase 2 Study of Inclisiran (formerly PCSK9si),2016-11-15 17:38:17 +0000,http://www.publicnow.com/view/DEF7E33466B78B042451EF73C0615EBB6EAFFD54,"[at noodls] - 11.15.2016 -Study meets all interim analysis goals- -A single injection of inclisiran (300 mg) lowered 'bad cholesterol' (LDL-C) by an average of 51%, and up to 76%- -Two injections of inclisiran (300 ..."
MDCO,MDCO:UW,BBG000DX6TV8,"MEDICINES CO /DE Files SEC form 8-K, Other Events",2016-11-15 16:56:46 +0000,http://biz.yahoo.com/e/161115/mdco8-k.html,"MEDICINES CO /DE Files SEC form 8-K, Other Events"
MDCO,MDCO:UW,BBG000DX6TV8,Long-lasting cholesterol lowering seen with Medicines Co drug -study,2016-11-15 16:54:38 +0000,http://finance.yahoo.com/news/long-lasting-cholesterol-lowering-seen-165438843.html,Long-lasting cholesterol lowering seen with Medicines Co drug -study
MDCO,MDCO:UW,BBG000DX6TV8,"ETFs with exposure to The Medicines Co. : November 14, 2016",2016-11-14 18:51:17 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-the-medicines-co-november-14-2016/,"ETFs with exposure to The Medicines Co. : November 14, 2016"
MDCO,MDCO:UW,BBG000DX6TV8,Alnylam Pharmaceuticals and The Medicines Company Announce Publication of Phase 1 Clinical Data with Inclisiran (ALN- PCSsc) in the New England Journal of Medicine,2016-11-13 22:57:10 +0000,http://www.publicnow.com/view/C376A912C3D1572102C50DDC30879ED811EB9009,[at noodls] - Alnylam Pharmaceuticals and The Medicines Company Announce Publication of Phase 1 Clinical Data with Inclisiran (ALN- PCSsc) in the New England Journal of Medicine The text version of this document is ...
MDCO,MDCO:UW,BBG000DX6TV8,Alnylam Pharmaceuticals and The Medicines Company Announce Publication of Phase 1 Clinical Data with Inclisiran (ALN- PCSsc) in the New England Journal of Medicine,2016-11-13 22:07:07 +0000,http://www.publicnow.com/view/D23FADE8317812F4B8DF7B68617FDEDF3E08B39F,[at noodls] - Alnylam Pharmaceuticals and The Medicines Company Announce Publication of Phase 1 Clinical Data with Inclisiran (ALN- PCSsc) in the New England Journal of Medicine The text version of this document is ...
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company to Host Conference Call and Webcast to Review Data from Ongoing ORION-1 Phase 2 Study of PCSK9si,2016-11-10 19:21:11 +0000,http://www.publicnow.com/view/0EC84B1D02A7410FD37B33CDE73521D96BC057CA,"[at noodls] - PARSIPPANY, N.J.--(BUSINESS WIRE)--Nov. 10, 2016-- The Medicines Company (NASDAQ: MDCO) will host a conference call and webcast on Tuesday, November 15, 2016, at 3:00 p.m., Eastern Time, to review data ..."
MDCO,MDCO:UW,BBG000DX6TV8,"The Medicines Co. :MDCO-US: Earnings Analysis: Q3, 2016 By the Numbers : November 10, 2016",2016-11-10 14:51:07 +0000,http://www.capitalcube.com/blog/index.php/the-medicines-co-mdco-us-earnings-analysis-q3-2016-by-the-numbers-november-10-2016/,"The Medicines Co. :MDCO-US: Earnings Analysis: Q3, 2016 By the Numbers : November 10, 2016"
MDCO,MDCO:UW,BBG000DX6TV8,"Biotech Stock Roundup: Ionis Soars on Spinraza Data, Regeneron's Q3 Results Mixed",2016-11-09 13:55:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/o62MSuZGffg/biotech-stock-roundup-ionis-soars-on-spinraza-data-regenerons-q3-results-mixed-cm706221,With third quarter earnings season winding down the only major biotech company to report results over the last five trading days was Regeneron REGN While some small and mid sized biotechs are yet to report results focus is back on pipeline and regulatory updates Recap of the Week s
MDCO,MDCO:UW,BBG000DX6TV8,"Biotech Stock Roundup: Ionis Soars on Spinraza Data, Regeneron's Q3 Results Mixed",2016-11-09 11:38:11 +0000,http://finance.yahoo.com/news/biotech-stock-roundup-ionis-soars-113811687.html,"Biotech Stock Roundup: Ionis Soars on Spinraza Data, Regeneron's Q3 Results Mixed"
MDCO,MDCO:UW,BBG000DX6TV8,Analyst Has 4 Biotech Stocks to Buy Now as Risk Has Dropped Dramatically,2016-11-08 14:55:40 +0000,http://247wallst.com/healthcare-business/2016/11/08/analyst-has-4-biotech-stocks-to-buy-now-as-risk-has-dropped-dramatically/,Analyst Has 4 Biotech Stocks to Buy Now as Risk Has Dropped Dramatically
MDCO,MDCO:UW,BBG000DX6TV8,"MDCO Tastes Bitter, PRTO Awaits Phase 3 Data In Dec., It''s Time To Cherish IONS",2016-11-08 05:07:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/M0DGzlGr9Js/mdco-tastes-bitter-prto-awaits-phase-3-data-in-dec-its-time-to-cherish-ions-20161108-00167,"MDCO Tastes Bitter, PRTO Awaits Phase 3 Data In Dec., It''s Time To Cherish IONS"
MDCO,MDCO:UW,BBG000DX6TV8,"The Medicines Company Discontinues Development of MDCO-216, its Investigational Cholesterol Efflux Promoter",2016-11-07 21:55:13 +0000,http://www.publicnow.com/view/E7D4A4953018ABFD6D1E8E68A61609144F961E70,"[at noodls] - - Top-line efficacy data from the MILANO-PILOT trial, which enrolled 126 patients, provide insufficient basis for further investment by the Company - - Discontinuation will enable the Company to reallocate ..."
MDCO,MDCO:UW,BBG000DX6TV8,"Which Four Biotechs Are Derisked, Buyable Ahead of Election Day?",2016-11-07 21:29:22 +0000,http://www.investors.com/news/technology/which-four-biotechs-are-derisked-buyable-ahead-of-election-day/,"Which Four Biotechs Are Derisked, Buyable Ahead of Election Day?"
MDCO,MDCO:UW,BBG000DX6TV8,"Alnylam Pharmaceuticals, Inc. Discloses Deaths, Waits for More Data",2016-11-05 20:27:32 +0000,http://www.fool.com/investing/2016/11/04/alnylam-pharmaceuticals-inc-discloses-deaths-waits.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Alnylam Pharmaceuticals, Inc. Discloses Deaths, Waits for More Data"
MDCO,MDCO:UW,BBG000DX6TV8,"Alnylam Pharmaceuticals, Inc. Discloses Deaths, Waits for More Data",2016-11-04 21:48:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ifcUVC7Z2b0/alnylam-pharmaceuticals-inc-discloses-deaths-waits-for-more-data-cm704399,Image source Getty Images Alnylam Pharmaceuticals NASDAQ ALNY fell 12 6 on Thursday after reporting earnings Wednesday afternoon but it s recovered some of that today Of course it wasn t the actual earnings that caused the decline for the record the biotech lost
MDCO,MDCO:UW,BBG000DX6TV8,10.6% of FTXH Holdings Seeing Recent Insider Buys,2016-11-04 14:09:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PvnEo10MTMs/106-of-ftxh-holdings-seeing-recent-insider-buys-cm703953,A look at the weighted underlying holdings of the First Trust Nasdaq Pharmaceuticals ETF Symbol FTXH shows an impressive 10 6 of holdings on a weighted basis have experienced insider buying within the past six months Abbott Laboratories Symbol ABT which makes up 8 55 of the
MDCO,MDCO:UW,BBG000DX6TV8,Biogen (BIIB) Helped Healthcare Funds Like This One Dominate The Third Quarter,2016-11-04 06:43:43 +0000,http://www.insidermonkey.com/blog/biogen-biib-helped-healthcare-funds-like-this-one-dominate-the-third-quarter-484895/,Biogen (BIIB) Helped Healthcare Funds Like This One Dominate The Third Quarter
MDCO,MDCO:UW,BBG000DX6TV8,"Alnylam (ALNY) Q3 Loss Wider than Expected, Revenues Up",2016-11-03 14:10:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0VuEQ4cZeFQ/alnylam-alny-q3-loss-wider-than-expected-revenues-up-cm703253,Alnylam Pharmaceuticals Inc ALNY reported a loss of 1 21 per share in the third quarter of 2016 wider than both the Zacks Consensus Estimate of a loss of 1 19 and the year ago figure of 91 cents FindTheCompany Graphiq Quarterly revenues on the other hand
MDCO,MDCO:UW,BBG000DX6TV8,9 Biotech Stocks to Put on Your Radar,2016-11-02 13:50:02 +0000,http://portal.kiplinger.com/slideshow/investing/T052-S015-9-biotech-stocks-to-put-on-your-radar/index.html?rid=SYN-yahoo&rpageid=15589,9 Biotech Stocks to Put on Your Radar
MDCO,MDCO:UW,BBG000DX6TV8,"Pfizer cholesterol drug fizzles, hitting shares",2016-11-01 20:28:20 +0000,http://sg.finance.yahoo.com/news/pfizer-cholesterol-drug-fizzles-hitting-202820724.html,"Pfizer cholesterol drug fizzles, hitting shares"
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Co. (MDCO) Q3 Loss Narrower than Expected,2016-10-27 16:46:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hoa1kLrNVSw/the-medicines-co-mdco-q3-loss-narrower-than-expected-cm699494,The Medicines Company MDCO reported a loss of 75 cents per share including the impact of share based compensation expenses in the third quarter of 2016 significantly narrower than both the Zacks Consensus Estimate of a loss of 1 38 and the year ago loss of 94 cents Meanwhile
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Co. (MDCO) Q3 Loss Narrower than Expected,2016-10-27 14:33:02 +0000,http://finance.yahoo.com/news/medicines-co-mdco-q3-loss-143302841.html,The Medicines Co. (MDCO) Q3 Loss Narrower than Expected
MDCO,MDCO:UW,BBG000DX6TV8,"MEDICINES CO /DE Files SEC form 10-Q, Quarterly Report",2016-10-27 11:37:46 +0000,http://biz.yahoo.com/e/161027/mdco10-q.html,"MEDICINES CO /DE Files SEC form 10-Q, Quarterly Report"
MDCO,MDCO:UW,BBG000DX6TV8,Edited Transcript of MDCO earnings conference call or presentation 26-Oct-16 12:30pm GMT,2016-10-26 18:01:38 +0000,http://finance.yahoo.com/news/edited-transcript-mdco-earnings-conference-180138828.html,Edited Transcript of MDCO earnings conference call or presentation 26-Oct-16 12:30pm GMT
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company Reports Third-Quarter 2016 Financial Results,2016-10-26 11:35:08 +0000,http://www.publicnow.com/view/CE78A58C1AE49E5C0147B67567DA6DD2B8E9EEFE,"[at noodls] - PARSIPPANY, N.J.--(BUSINESS WIRE)--Oct. 26, 2016-- The Medicines Company (NASDAQ:MDCO) today announced its financial results for the third quarter ended September 30, 2016. ... This is an abstract of the ..."
MDCO,MDCO:UW,BBG000DX6TV8,Medicines Co. reports 3Q loss,2016-10-26 11:12:43 +0000,http://sg.finance.yahoo.com/news/medicines-co-reports-3q-loss-111243955.html,Medicines Co. reports 3Q loss
MDCO,MDCO:UW,BBG000DX6TV8,"MEDICINES CO /DE Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits",2016-10-26 11:07:36 +0000,http://biz.yahoo.com/e/161026/mdco8-k.html,"MEDICINES CO /DE Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits"
MDCO,MDCO:UW,BBG000DX6TV8,Q3 2016 Medicines Co Earnings Release - Before Market Open,2016-10-26 11:07:04 +0000,http://biz.yahoo.com/research/earncal/20161026.html?t=mdco,Q3 2016 Medicines Co Earnings Release - Before Market Open
MDCO,MDCO:UW,BBG000DX6TV8,"Drug Stock Earnings to Watch on Oct 26: BIIB, MDCO & More",2016-10-25 13:26:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2lwFmTsnxU0/drug-stock-earnings-to-watch-on-oct-26-biib-mdco-more-cm697724,With Q3 earnings picking up pace approximately 116 S amp P 500 members representing 23 2 of the index s total market capitalization have already reported quarterly results as of Oct 21 An impressive 80 2 of these companies managed to post an earnings beat while 62 9
MDCO,MDCO:UW,BBG000DX6TV8,"Drug Stock Earnings to Watch on Oct 26: BIIB, MDCO & More",2016-10-25 12:27:12 +0000,http://finance.yahoo.com/news/drug-stock-earnings-watch-oct-122712297.html,"Drug Stock Earnings to Watch on Oct 26: BIIB, MDCO & More"
MDCO,MDCO:UW,BBG000DX6TV8,"Biotech Stock Roundup: ARIAD Down on Drug Pricing Tweet, Regeneron Study on Clinical Hold",2016-10-19 16:51:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6egD9qN3o2A/biotech-stock-roundup-ariad-down-on-drug-pricing-tweet-regeneron-study-on-clinical-hold-cm695455,Once again a single tweet on drug pricing resulted in weakness in the biotech sector with ARIAD ARIA losing ground on a tweet regarding the company s price hikes for cancer drug Iclusig Meanwhile Regeneron REGN suffered a pipeline setback with the FDA putting a clinical hold on one of
MDCO,MDCO:UW,BBG000DX6TV8,"Biotech Stock Roundup: ARIAD Down on Drug Pricing Tweet, Regeneron Study on Clinical Hold",2016-10-19 14:11:02 +0000,http://finance.yahoo.com/news/biotech-stock-roundup-ariad-down-141102115.html,"Biotech Stock Roundup: ARIAD Down on Drug Pricing Tweet, Regeneron Study on Clinical Hold"
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company (MDCO) in Focus: Stock Rises 6%,2016-10-19 13:50:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UjdfInEsKko/the-medicines-company-mdco-in-focus-stock-rises-6-cm695194,The Medicines Company MDCO was a big mover last session as the company saw its shares rise nearly 6 on the day The uptrend was driven by the firm s highly competitive phase one data on a cholesterol lowering drug with bullish views on it 90 days into phase two testing This resulted in
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Co. Reports Positive Phase II Data on PCSK9si,2016-10-19 13:50:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XHtPaNtTCpE/the-medicines-co-reports-positive-phase-ii-data-on-pcsk9si-cm695305,The Medicines Company MDCO announced positive top line results from a Day 90 interim analysis of the ongoing ORION 1 phase II study of its pipeline candidate PCSK9si for the treatment of hypercholesterolemia PCSK9si earlier known as ALN PCSsc is a first in class
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Co. Reports Positive Phase II Data on PCSK9si,2016-10-19 12:30:12 +0000,http://finance.yahoo.com/news/medicines-co-reports-positive-phase-123012474.html,The Medicines Co. Reports Positive Phase II Data on PCSK9si
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company (MDCO) in Focus: Stock Rises 6%,2016-10-19 12:00:12 +0000,http://finance.yahoo.com/news/medicines-company-mdco-focus-stock-120012825.html,The Medicines Company (MDCO) in Focus: Stock Rises 6%
MDCO,MDCO:UW,BBG000DX6TV8,Decsontructing The Latest The Medicines Company (MDCO) Release,2016-10-19 11:06:50 +0000,http://www.insidermonkey.com/blog/decsontructing-the-latest-the-medicines-company-mdco-release-482096/,Decsontructing The Latest The Medicines Company (MDCO) Release
MDCO,MDCO:UW,BBG000DX6TV8,Medicines Co. Jumps On Bullish Cholesterol-Drug Views,2016-10-18 20:47:59 +0000,http://www.investors.com/news/technology/medicines-co-flirts-with-buy-point-on-bullish-cholesterol-drug-views/,Medicines Co. Jumps On Bullish Cholesterol-Drug Views
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company Announces Positive Top-Line Results from Day 90 Interim Analysis in Ongoing ORION-1 Phase 2 Study of PCSK9si,2016-10-18 11:33:02 +0000,http://www.publicnow.com/view/50EE6769C09E7FD57803DAE7CB5EDB5DFD9FDD85,[at noodls] - - Compelling efficacy and safety data from ORION-1 interim analysis confirm results up to Day 90 from PCSK9si Phase 1 study and significantly exceed ORION-1 study objectives - - PCSK9si again demonstrated ...
MDCO,MDCO:UW,BBG000DX6TV8,"The Medicines Company to Announce Third Quarter Financial Results on October 26, 2016",2016-10-17 20:43:00 +0000,http://www.publicnow.com/view/9CF3DDCF8AA10676EC3040004AA6DC707A173220,"[at noodls] - PARSIPPANY, N.J.--(BUSINESS WIRE)--Oct. 17, 2016-- The Medicines Company (NASDAQ:MDCO) has scheduled its quarterly conference call forOctober 26, 2016 at 8:30 a.m., Eastern Daylight Time, to discuss third-quarter ..."
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company’s Infectious Disease Portfolio Featured in 16 Presentations at IDWeek 2016,2016-10-17 11:30:00 +0000,http://finance.yahoo.com/news/medicines-company-infectious-disease-portfolio-113000486.html,"[Business Wire] - The Medicines Company today announced that data from its portfolio of antimicrobial products and product candidates will be featured in 16 presentations at IDWeek 2016, to be held October 26-30, 2016, in New Orleans."
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company to Present Data from its Investigational Anesthetic MDCO-700 at the ANESTHESIOLOGY® 2016 Annual Meeting and the ISAP 25th Annual Meeting,2016-10-13 11:30:00 +0000,http://finance.yahoo.com/news/medicines-company-present-data-investigational-113000114.html,"[Business Wire] - The Medicines Company today announced that five abstracts with data from its investigational anesthetic MDCO-700 development program will be presented at ANESTHESIOLOGY® 2016, the annual meeting of the American Society of Anesthesiologists , being held at the McCormick Place in Chicago from October 22-26, 2016 and at the International Society for Anaesthetic Pharmacology 25th Annual Meeting taking ..."
MDCO,MDCO:UW,BBG000DX6TV8,Top Biotech Plays Highlight Jefferies Growth Stocks to Buy,2016-10-12 13:55:50 +0000,http://247wallst.com/healthcare-business/2016/10/12/top-biotech-plays-highlight-jefferies-growth-stocks-to-buy/,Top Biotech Plays Highlight Jefferies Growth Stocks to Buy
MDCO,MDCO:UW,BBG000DX6TV8,"What's Next for Alnylam Pharmaceuticals, Inc. After Its Phase 3 Failure?",2016-10-07 15:46:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pMxfuBstiWo/whats-next-for-alnylam-pharmaceuticals-inc-after-its-phase-3-failure-cm690338,Image source Getty Images Another once promising drug has failed Alnylam Pharmaceuticals NASDAQ ALNY announced on Oct 5 that it was discontinuing development of revusiran in treating hereditary ATTR amyloidosis with cardiomyopathy hATTR CM The drug had been in a late
MDCO,MDCO:UW,BBG000DX6TV8,"What's Next for Alnylam Pharmaceuticals, Inc. After Its Phase 3 Failure?",2016-10-07 14:28:00 +0000,http://www.fool.com/investing/2016/10/07/whats-next-for-alnylam-pharmaceuticals-inc-after-i.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"What's Next for Alnylam Pharmaceuticals, Inc. After Its Phase 3 Failure?"
MDCO,MDCO:UW,BBG000DX6TV8,UPDATE: Alnylam: A $2.8 Billion Bad Day,2016-10-06 21:45:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/10/06/alnylam-a-2-8-billion-bad-day/?mod=yahoobarrons&ru=yahoo,UPDATE: Alnylam: A $2.8 Billion Bad Day
MDCO,MDCO:UW,BBG000DX6TV8,Indexes Close Mixed As Medicals Sicken; 3 Little-Known Stocks Move Bullishly,2016-10-06 20:04:35 +0000,http://www.investors.com/market-trend/stock-market-today/indexes-mixed-as-medicals-tumble-3-little-known-stocks-move-bullishly/,Indexes Close Mixed As Medicals Sicken; 3 Little-Known Stocks Move Bullishly
MDCO,MDCO:UW,BBG000DX6TV8,Notable Two Hundred Day Moving Average Cross - MDCO,2016-10-06 18:43:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xSQIQr4mrAY/notable-two-hundred-day-moving-average-cross-mdco-cm689956,In trading on Thursday shares of Medicines Co Symbol MDCO crossed below their 200 day moving average of 35 35 changing hands as low as 32 31 per share Medicines Co shares are currently trading down about 12 2 on the day The chart below shows the one year performance of MDCO shares
MDCO,MDCO:UW,BBG000DX6TV8,Why The Medicines Company's Share Price Got Sick Today,2016-10-06 18:43:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aZxBPB7hZ6c/why-the-medicines-companys-share-price-got-sick-today-cm689946,Image source Getty Images What happened The Medicines Company NASDAQ MDCO is down 11 at 12 39 p m EDT after its partner Alnylam Pharmaceuticals NASDAQ ALNY announced yesterday afternoon that it s stopping development of one of its drug candidates revusiran
MDCO,MDCO:UW,BBG000DX6TV8,Medicines Becomes Oversold (MDCO),2016-10-06 18:43:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/L286dR5gCnc/medicines-becomes-oversold-mdco-cm689952,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
MDCO,MDCO:UW,BBG000DX6TV8,"Thursday Sector Laggards: Precious Metals, Drugs",2016-10-06 18:43:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5qEzPxGY12w/thursday-sector-laggards-precious-metals-drugs-cm689945,In trading on Thursday precious metals shares were relative laggards down on the day by about 3 4 Helping drag down the group were shares of Vista Gold VGZ down about 9 5 and shares of Platinum Group Metals PLG off about 9 3 on the day Also lagging the market Thursday
MDCO,MDCO:UW,BBG000DX6TV8,Mid-Day Market Update: Aurinia Pharmaceuticals Gains On AURION Data; Twitter Shares Slide,2016-10-06 17:33:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hYlh4Ipg2a0/mid-day-market-update-aurinia-pharmaceuticals-gains-on-aurion-data-twitter-shares-slide-cm689938,Midway through trading Thursday the Dow traded down 0 10 percent to 18 263 74 while the NASDAQ declined 0 12 percent to 5 309 47 The S amp P also fell dropping 0 03 percent to 2 160 42 Leading and Lagging Sectors On Thursday non cyclical consumer goods amp services
MDCO,MDCO:UW,BBG000DX6TV8,Why The Medicines Company's Share Price Got Sick Today,2016-10-06 17:17:23 +0000,http://www.fool.com/investing/2016/10/06/why-the-medicines-companys-share-price-got-sick-to.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why The Medicines Company's Share Price Got Sick Today
MDCO,MDCO:UW,BBG000DX6TV8,Why Medicines Co. (MDCO) Stock is Falling Today,2016-10-06 17:04:00 +0000,https://www.thestreet.com/story/13844520/1/why-medicines-co-mdco-stock-is-falling-today.html?puc=yahoo&cm_ven=YAHOO,Why Medicines Co. (MDCO) Stock is Falling Today
MDCO,MDCO:UW,BBG000DX6TV8,Is Medicines Co. Getting Infected by Alnylam's Woes?,2016-10-06 16:15:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/10/06/is-medicines-co-getting-infected-by-alnylams-woes/?mod=yahoobarrons&ru=yahoo,Is Medicines Co. Getting Infected by Alnylam's Woes?
MDCO,MDCO:UW,BBG000DX6TV8,Mid-Morning Market Update: Markets Open Lower; Yum! Brands Sales Miss Estimates,2016-10-06 15:28:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3NL1RjvyDxQ/mid-morning-market-update-markets-open-lower-yum-brands-sales-miss-estimates-cm689800,Following the market opening Thursday the Dow traded down 0 64 percent to 18 164 68 while the NASDAQ declined 0 50 percent to 5 289 41 The S amp P also fell dropping 0 36 percent to 2 151 97 Leading and Lagging Sectors Thursday morning energy shares gained by 0 50
MDCO,MDCO:UW,BBG000DX6TV8,"Pre-Market Most Active for Oct 6, 2016 :  TWTR, KLAC, AUPH, SNY, CRM, ALNY, RDS/B, NOK, LRCX, WMT, MDCO, JD",2016-10-06 12:53:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5k1OPsId62M/pre-market-most-active-for-oct-6-2016-twtr-klac-auph-sny-crm-alny-rdsb-nok-lrcx-wmt-mdco-jd-cm689589,The NASDAQ 100 Pre Market Indicator is up 19 to 4 877 94 The total Pre Market volume is currently 11 202 484 shares traded The following are the most active stocks for the pre market session Twitter Inc TWTR is 3 97 at 20 90 with 7 159 866 shares traded TWTR
MDCO,MDCO:UW,BBG000DX6TV8,7 Key FDA Decisions and Clinical Trial Results Coming in Q4,2016-10-06 12:35:23 +0000,http://247wallst.com/healthcare-business/2016/10/06/7-key-fda-decisions-and-clinical-trial-results-coming-in-q4/,7 Key FDA Decisions and Clinical Trial Results Coming in Q4
MDCO,MDCO:UW,BBG000DX6TV8,"Why Yum, Booz Allen Hamilton, Alnylam, and More Are in the Spotlight",2016-10-06 04:32:26 +0000,http://www.insidermonkey.com/blog/why-yum-booz-allen-hamilton-alnylam-and-more-are-in-the-spotlight-478914/,"Why Yum, Booz Allen Hamilton, Alnylam, and More Are in the Spotlight"
MDCO,MDCO:UW,BBG000DX6TV8,"ALNY''s ENDEAVOUR Goes In Vain, ALQA Gains Big In After-Hrs, SCYX On The Move",2016-10-06 02:09:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2SDigWNDUZE/alnys-endeavour-goes-in-vain-alqa-gains-big-in-afterhrs-scyx-on-the-move-20161006-01126,"ALNY''s ENDEAVOUR Goes In Vain, ALQA Gains Big In After-Hrs, SCYX On The Move"
MDCO,MDCO:UW,BBG000DX6TV8,"ALNY's ENDEAVOUR Goes In Vain, ALQA Gains Big In After-Hrs, SCYX On The Move",2016-10-06 02:09:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WU-WqiLOTm0/alnys-endeavour-goes-in-vain-alqa-gains-big-in-afterhrs-scyx-on-the-move-20161006-00026,"ALNY's ENDEAVOUR Goes In Vain, ALQA Gains Big In After-Hrs, SCYX On The Move"
MDCO,MDCO:UW,BBG000DX6TV8,Alynlam Dives After Ending Heart Drug Development On 'Mortality Imbalance',2016-10-05 21:41:20 +0000,http://www.investors.com/news/technology/alynlam-dives-after-ending-heart-drug-development-on-mortality-imbalance/,Alynlam Dives After Ending Heart Drug Development On 'Mortality Imbalance'
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company Provides Progress Update on Ongoing ORION-1 Study of PCSK9si,2016-10-05 20:58:05 +0000,http://www.publicnow.com/view/2DA5443F647102602EBC9C268C7484D2BDD9E35D,"[at noodls] - -Results from ORION-1 interim analysis with Day 90 follow-up will be presented in Late-Breaking Clinical Trial Session at American Heart Association (AHA) meeting on November 15, 2016- -The Company anticipates ..."
MDCO,MDCO:UW,BBG000DX6TV8,10 Biotech Stocks to Put on Your Radar This Quarter,2016-10-04 20:46:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/n7v6LCPRO3c/10-biotech-stocks-to-put-on-your-radar-this-quarter-cm688122,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips While the foreseeable future for the broad market may not be clear there s one group that still moves independently of stocks as a whole biotech stocks
MDCO,MDCO:UW,BBG000DX6TV8,"The Medicines Co. breached its 50 day moving average in a Bearish Manner : MDCO-US : September 30, 2016",2016-09-30 12:29:00 +0000,http://www.capitalcube.com/blog/index.php/the-medicines-co-breached-its-50-day-moving-average-in-a-bearish-manner-mdco-us-september-30-2016/,"The Medicines Co. breached its 50 day moving average in a Bearish Manner : MDCO-US : September 30, 2016"
MDCO,MDCO:UW,BBG000DX6TV8,We Did The Math IYY Can Go To $118,2016-09-27 14:21:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nZ74uq3Ioxw/we-did-the-math-iyy-can-go-to-118-cm685289,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
MDCO,MDCO:UW,BBG000DX6TV8,"Notable Friday Option Activity: IMPV, MDCO, YELP",2016-09-23 17:22:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cwkXN8lwa5Q/notable-friday-option-activity-impv-mdco-yelp-cm683897,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Imperva Inc Symbol IMPV where a total volume of 13 486 contracts has been traded thus far today a contract volume which is representative of approximately 1 3
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Co. to Get BARDA Funding for Infection Drugs,2016-09-22 15:23:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HC6wS6No6Qo/the-medicines-co-to-get-barda-funding-for-infection-drugs-cm683118,The Medicines Company MDCO announced a new strategic partnership with the Biomedical Advanced Research and Development Authority BARDA under which the company will receive funding for the development of new antibiotics targeting drug resistant infections The partnership was inked
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Co. to Get BARDA Funding for Infection Drugs,2016-09-22 13:29:01 +0000,http://finance.yahoo.com/news/medicines-co-barda-funding-infection-132901754.html,The Medicines Co. to Get BARDA Funding for Infection Drugs
MDCO,MDCO:UW,BBG000DX6TV8,Blog Coverage Medicines Company in a Strategic Partnership with BARDA to Develop a New Range of Antibiotics,2016-09-22 13:18:17 +0000,http://news.investornetwork.com/2016/09/22/blog-coverage-medicines-company-in-a-strategic-partnership-with-barda-to-develop-a-new-range-of-antibiotics/?1=1&1474550297,Blog Coverage Medicines Company in a Strategic Partnership with BARDA to Develop a New Range of Antibiotics
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company Awarded up to $132 Million to Develop Portfolio of New Antibiotics Targeting Drug-Resistant Infections under Strategic Partnership with BARDA,2016-09-21 11:51:03 +0000,http://www.publicnow.com/view/93D6D0ECD135B34EF52A7B4532AA93EDBD8C2854,"[at noodls] - -Provides up to $132 million to support development of the Company's leading pipeline of antibiotics targeting drug-resistant bacteria, including the ongoing development of CARBAVANCE® (meropenem-vaborbactam)- ..."
MDCO,MDCO:UW,BBG000DX6TV8,"U.S. to invest in Medicines Co, Roche antibiotics development",2016-09-21 11:30:01 +0000,http://finance.yahoo.com/news/u-invest-medicines-co-roche-113001765.html,"[Reuters] - The Medicines Co on Wednesday said it will receive up to $132 million in U.S. government funding for development of new antibiotics to fight drug-resistant infections, seen by health officials as a critically important need. Under terms of the agreement, the company said it will receive $32 million in initial funding from BARDA, the Biomedical Advanced Research and Development Authority, a division of the U.S. Department of Health and Human Services. Medicines Co would be eligible to receive up to an additional $100 million over five years if BARDA exercises all of its options to extend the partnership, the company said."
MDCO,MDCO:UW,BBG000DX6TV8,"ETF’s with exposure to The Medicines Co. : September 14, 2016",2016-09-14 14:20:40 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-the-medicines-co-september-14-2016/,"ETF’s with exposure to The Medicines Co. : September 14, 2016"
MDCO,MDCO:UW,BBG000DX6TV8,"The Medicines Co. – Value Analysis (NASDAQ:MDCO) : September 13, 2016",2016-09-13 15:41:55 +0000,http://www.capitalcube.com/blog/index.php/the-medicines-co-value-analysis-nasdaqmdco-september-13-2016/,"The Medicines Co. – Value Analysis (NASDAQ:MDCO) : September 13, 2016"
MDCO,MDCO:UW,BBG000DX6TV8,"The Medicines Co. breached its 50 day moving average in a Bearish Manner : MDCO-US : September 12, 2016",2016-09-12 13:16:05 +0000,http://www.capitalcube.com/blog/index.php/the-medicines-co-breached-its-50-day-moving-average-in-a-bearish-manner-mdco-us-september-12-2016/,"The Medicines Co. breached its 50 day moving average in a Bearish Manner : MDCO-US : September 12, 2016"
MDCO,MDCO:UW,BBG000DX6TV8,CORRECTING and REPLACING The Medicines Company Provides Update on Dyslipidemia Programs,2016-08-31 19:25:00 +0000,http://finance.yahoo.com/news/correcting-replacing-medicines-company-provides-192500108.html,"[Business Wire] - The third paragraph of release dated August 30, 2016, should read: The Company has completed enrollment of the planned 120 patients and expects that results from the MILANO-PILOT study will be presented by its principal investigator, Dr."
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Co. Offers Update on Dyslipidemia Programs,2016-08-31 16:16:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MiefBNzhg-c/the-medicines-co-offers-update-on-dyslipidemia-programs-cm672871,The Medicines CompanyMDCO came up with important announcements related to its pipeline. The company provided an update on its dyslipidemia programs   MDCO 216 (which contains APoA 1 Milano) and PCSK9si (PCSK9 synthesis inhibitor).  MDCO
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Co. Offers Update on Dyslipidemia Programs,2016-08-31 14:13:02 +0000,http://finance.yahoo.com/news/medicines-co-offers-dyslipidemia-programs-141302288.html,The Medicines Co. Offers Update on Dyslipidemia Programs
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company Provides Update on Dyslipidemia Programs,2016-08-30 21:23:06 +0000,http://www.publicnow.com/view/8AD11D4E8941519862958C0968AB5F83E50822CC,"[at noodls] - PARSIPPANY, N.J.--(BUSINESS WIRE)--Aug. 30, 2016-- The Medicines Company (NASDAQ:MDCO) today provided an update on its clinical dyslipidemia research programs for MDCO-216 (which contains APoA-1 Milano) ..."
MDCO,MDCO:UW,BBG000DX6TV8,Medicines Co. shares drop as early drug trial results not promising,2016-08-30 20:56:17 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=4051F189-7258-4A07-857B-069C9B1099AB&siteid=yhoof2,Medicines Co. shares drop as early drug trial results not promising
MDCO,MDCO:UW,BBG000DX6TV8,"ETF’s with exposure to The Medicines Co. : August 30, 2016",2016-08-30 15:21:11 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-the-medicines-co-august-30-2016/,"ETF’s with exposure to The Medicines Co. : August 30, 2016"
MDCO,MDCO:UW,BBG000DX6TV8,"5 Trade Ideas for Monday: Apache, E*TRADE, Medicines Company, MGP Ingredients and PNC",2016-08-28 15:27:10 +0000,http://finance.yahoo.com/tumblr/blog-5-trade-ideas-for-monday-apache-etrade-152713633.html,"5 Trade Ideas for Monday: Apache, E*TRADE, Medicines Company, MGP Ingredients and PNC"
MDCO,MDCO:UW,BBG000DX6TV8,Mallinckrodt to Divest Nuclear Imaging Business for $690M,2016-08-25 13:48:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ptM533U_DIQ/mallinckrodt-to-divest-nuclear-imaging-business-for-690m-cm670064,"Mallinckrodt plcMNK announced that it has entered into a definitive agreement to sell its Nuclear Imaging business to IBA Molecular for $690 million.  Of the total value of the deal, approximately $574 million comprises up front"
MDCO,MDCO:UW,BBG000DX6TV8,"MEDICINES CO /DE Files SEC form 8-K, Change in Directors or Principal Officers",2016-08-18 20:49:01 +0000,http://biz.yahoo.com/e/160818/mdco8-k.html,"MEDICINES CO /DE Files SEC form 8-K, Change in Directors or Principal Officers"
MDCO,MDCO:UW,BBG000DX6TV8,"Alnylam Pharmaceuticals, Inc. Cranks Out the Data",2016-08-12 21:34:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mejcINpFEJc/alnylam-pharmaceuticals-inc-cranks-out-the-data-cm664913,Image source  Getty Images.  There isn't much to say about Alnylam Pharmaceuticals '(NASDAQ  ALNY) second quarter earnings    or lack thereof    but it certainly was a data
MDCO,MDCO:UW,BBG000DX6TV8,Mallinckrodt (MNK) to Buy Stratatech for Undisclosed Value,2016-08-12 18:49:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rTDr8tVuNEg/mallinckrodt-mnk-to-buy-stratatech-for-undisclosed-value-cm664814,"Mallinckrodt plcMNK announced that it will acquire privately held regenerative medicine company, Stratatech Corporation. However, financial terms of the transaction were not disclosed. The transaction will close in the second half of the year. Assets Acquired through the Deal"
MDCO,MDCO:UW,BBG000DX6TV8,Mallinckrodt (MNK) to Buy Stratatech for Undisclosed Value,2016-08-12 16:24:04 +0000,http://finance.yahoo.com/news/mallinckrodt-mnk-buy-stratatech-undisclosed-162404386.html,Mallinckrodt (MNK) to Buy Stratatech for Undisclosed Value
MDCO,MDCO:UW,BBG000DX6TV8,"ETF’s with exposure to The Medicines Co. : August 11, 2016",2016-08-11 16:56:27 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-the-medicines-co-august-11-2016/,"ETF’s with exposure to The Medicines Co. : August 11, 2016"
MDCO,MDCO:UW,BBG000DX6TV8,"The Medicines Co. :MDCO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 8, 2016",2016-08-08 16:55:26 +0000,http://www.capitalcube.com/blog/index.php/the-medicines-co-mdco-us-earnings-analysis-q2-2016-by-the-numbers-august-8-2016/,"The Medicines Co. :MDCO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 8, 2016"
MDCO,MDCO:UW,BBG000DX6TV8,"MEDICINES CO /DE Files SEC form 10-Q, Quarterly Report",2016-08-05 10:56:28 +0000,http://biz.yahoo.com/e/160805/mdco10-q.html,"MEDICINES CO /DE Files SEC form 10-Q, Quarterly Report"
MDCO,MDCO:UW,BBG000DX6TV8,Come Take Your Medicine (Company),2016-08-04 16:04:27 +0000,http://finance.yahoo.com/tumblr/blog-come-take-your-medicine-company-160432303.html,Come Take Your Medicine (Company)
MDCO,MDCO:UW,BBG000DX6TV8,Insiders Bullish on Certain Holdings of JKJ,2016-08-01 14:51:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vDjPqawnOzI/insiders-bullish-on-certain-holdings-of-jkj-cm657954,A look at the weighted underlying holdings of the iShares Morningstar Small Cap ETF ( JKJ ) shows an impressive 12.9% of holdings on a weighted basis have experienced insider buying within the past six months. Medicines Co (Symbol
MDCO,MDCO:UW,BBG000DX6TV8,Mallinckrodt (MNK) Q3 Earnings: Will the Stock Surprise?,2016-07-28 01:22:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QtCyMgBqWJo/mallinckrodt-mnk-q3-earnings-will-the-stock-surprise-cm656136,"Mallinckrodt plcMNK is set to report third quarter fiscal 2016 results on Aug 2. The company's track record has been impressive so far. It has beaten estimates in all of the last four quarters, with a positive average earnings"
MDCO,MDCO:UW,BBG000DX6TV8,Edited Transcript of MDCO earnings conference call or presentation 27-Jul-16 12:30pm GMT,2016-07-28 01:11:12 +0000,http://finance.yahoo.com/news/edited-transcript-mdco-earnings-conference-011112190.html,Edited Transcript of MDCO earnings conference call or presentation 27-Jul-16 12:30pm GMT
MDCO,MDCO:UW,BBG000DX6TV8,Mallinckrodt (MNK) Q3 Earnings: Will the Stock Surprise?,2016-07-27 22:47:10 +0000,http://finance.yahoo.com/news/mallinckrodt-mnk-q3-earnings-stock-224710203.html,Mallinckrodt (MNK) Q3 Earnings: Will the Stock Surprise?
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company Reports Second-Quarter 2016 Business and Financial Results,2016-07-27 11:48:06 +0000,http://www.publicnow.com/view/AE8AEADECED475B19EE4AAC4B31D5F68FD97363A,[at noodls] - - Advanced potential blockbuster R&D programs - - Completed divestiture of non-core cardiovascular assets - - Refinanced substantial portion of near-term debt obligations - - Transactions significantly ...
MDCO,MDCO:UW,BBG000DX6TV8,Medicines Co. posts 2Q profit,2016-07-27 11:36:40 +0000,http://sg.finance.yahoo.com/news/medicines-co-posts-2q-profit-113640862.html,Medicines Co. posts 2Q profit
MDCO,MDCO:UW,BBG000DX6TV8,Q2 2016 Medicines Co Earnings Release - Before Market Open,2016-07-27 11:07:05 +0000,http://biz.yahoo.com/research/earncal/20160727.html?t=mdco,Q2 2016 Medicines Co Earnings Release - Before Market Open
MDCO,MDCO:UW,BBG000DX6TV8,"MEDICINES CO /DE Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits",2016-07-27 11:05:41 +0000,http://biz.yahoo.com/e/160727/mdco8-k.html,"MEDICINES CO /DE Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits"
MDCO,MDCO:UW,BBG000DX6TV8,"5 Drug Stocks' Earnings on Jul 27: AMGN, VRTX & More",2016-07-26 16:29:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fREEVb1_5bM/5-drug-stocks-earnings-on-jul-27-amgn-vrtx-more-cm654920,"With Q2 earnings picking up pace, approximately 126 S&P 500 members (representing 32.7% of the index's total market capitalization) have reported quarterly results as of Jul 22. An impressive 70.6% of these companies managed to record an earnings beat,"
MDCO,MDCO:UW,BBG000DX6TV8,"5 Drug Stocks' Earnings on Jul 27: AMGN, VRTX & More",2016-07-26 14:36:02 +0000,http://finance.yahoo.com/news/5-drug-stocks-earnings-jul-143602567.html,"5 Drug Stocks' Earnings on Jul 27: AMGN, VRTX & More"
MDCO,MDCO:UW,BBG000DX6TV8,Call buyers targeting Medicines Company,2016-07-20 12:14:30 +0000,http://finance.yahoo.com/news/call-buyers-targeting-medicines-company-121430862.html,Call buyers targeting Medicines Company
MDCO,MDCO:UW,BBG000DX6TV8,"The Medicines Company to Announce Second Quarter Financial Results on July 27, 2016",2016-07-18 11:00:00 +0000,http://finance.yahoo.com/news/medicines-company-announce-second-quarter-110000495.html,"[Business Wire] - The Medicines Company has scheduled its quarterly conference call for July 27, 2016 at 8:30 a.m. Eastern Time to discuss second quarter financial results and operational developments."
MDCO,MDCO:UW,BBG000DX6TV8,"The Medicines Co. breached its 50 day moving average in a Bullish Manner : MDCO-US : July 12, 2016",2016-07-12 12:33:32 +0000,http://www.capitalcube.com/blog/index.php/the-medicines-co-breached-its-50-day-moving-average-in-a-bullish-manner-mdco-us-july-12-2016/,"The Medicines Co. breached its 50 day moving average in a Bullish Manner : MDCO-US : July 12, 2016"
MDCO,MDCO:UW,BBG000DX6TV8,Federal Circuit Rules for The Medicines Company in Angiomax® (bivalirudin) Patent Litigation,2016-07-12 11:33:02 +0000,http://www.publicnow.com/view/4E7D81E2706EE76B137BE1AEB183116D251328EB,"[at noodls] - The Federal Circuit unanimously affirms District Circuit decision on Angiomax patents PARSIPPANY, N.J.--(BUSINESS WIRE)--Jul. 12, 2016-- The Medicines Company announced that the U.S. Court of Appeals for ..."
MDCO,MDCO:UW,BBG000DX6TV8,Medicines (MDCO) Shares Cross Above 200 DMA,2016-07-11 16:48:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ok5poJqaTek/medicines-mdco-shares-cross-above-200-dma-cm647220,"In trading on Monday, shares of Medicines Co (Symbol MDCO) crossed above their 200 day moving average of $35.38, changing hands as high as $39.00 per share. Medicines Co shares are currently trading up about 3.5% on the day."
MDCO,MDCO:UW,BBG000DX6TV8,Medicines Co. (MDCO) Has Suddenly Spiked To The Upside,2016-07-11 10:13:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KiQ39rjd8lc/medicines-co-mdco-has-suddenly-spiked-to-the-upside-20160711-00560,Medicines Co. (MDCO) Has Suddenly Spiked To The Upside
MDCO,MDCO:UW,BBG000DX6TV8,Why Did Alnylam Pharmaceuticals’s Valuation Multiples Drop in 2016?,2016-07-09 01:23:02 +0000,http://marketrealist.com/2016/07/alnylam-pharmaceuticals-witnessed-strong-drop-valuation-multiples-2016/?utm_source=yahoo&utm_medium=feed,Why Did Alnylam Pharmaceuticals’s Valuation Multiples Drop in 2016?
MDCO,MDCO:UW,BBG000DX6TV8,http://news.investornetwork.com/2016/07/07/coverage-initiated-on-select-healthcare-equities/,2016-07-07 13:02:19 +0000,http://news.investornetwork.com/2016/07/07/coverage-initiated-on-select-healthcare-equities/?1=1&1467896539,http://news.investornetwork.com/2016/07/07/coverage-initiated-on-select-healthcare-equities/
MDCO,MDCO:UW,BBG000DX6TV8,"The Zacks Analyst Blog Highlights: Gilead, Regulus, AbbVie, The Medicines and GW Pharma",2016-06-30 15:53:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/swngwd4kqpQ/the-zacks-analyst-blog-highlights-gilead-regulus-abbvie-the-medicines-and-gw-pharma-cm643290,"For Immediate Release Chicago, IL June 30, 2016 Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks"
MDCO,MDCO:UW,BBG000DX6TV8,"The Zacks Analyst Blog Highlights: Gilead, Regulus, AbbVie, The Medicines and GW Pharma",2016-06-30 13:30:01 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-gilead-133001456.html,"The Zacks Analyst Blog Highlights: Gilead, Regulus, AbbVie, The Medicines and GW Pharma"
MDCO,MDCO:UW,BBG000DX6TV8,"Biotech Stock Roundup: Gilead Gets FDA Nod for HCV Drug, Regulus Hit by Clinical Hold",2016-06-29 20:51:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_vawUQPECbQ/biotech-stock-roundup-gilead-gets-fda-nod-for-hcv-drug-regulus-hit-by-clinical-hold-cm642890,"Gilead GILD once again showed its expertise in the hepatitis C virus (HCV) segment by gaining FDA approval for yet another drug, Epclusa. However, another company, Regulus RGLS suffered a setback related to its experimental HCV treatment.  Recap of"
MDCO,MDCO:UW,BBG000DX6TV8,"Biotech Stock Roundup: Gilead Gets FDA Nod for HCV Drug, Regulus Hit by Clinical Hold",2016-06-29 18:23:06 +0000,http://finance.yahoo.com/news/biotech-stock-roundup-gilead-gets-182306522.html,"Biotech Stock Roundup: Gilead Gets FDA Nod for HCV Drug, Regulus Hit by Clinical Hold"
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Co.'s Carbavance Scores in Phase III Study,2016-06-28 16:51:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sW2q4miYBzg/the-medicines-cos-carbavance-scores-in-phase-iii-study-cm642146,"The Medicines CompanyMDCO got some good news on the pipeline front with its experimental antibiotic, Carbavance meeting FDA as well as EMA pre specified primary endpoints in a late stage study (TANGO I) conducted in patients with complicated urinary"
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Co.'s Carbavance Scores in Phase III Study,2016-06-28 14:45:02 +0000,http://finance.yahoo.com/news/medicines-co-carbavance-scores-phase-144502100.html,The Medicines Co.'s Carbavance Scores in Phase III Study
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company Announces Positive Top- Line Results for Phase 3 TANGO 1 Clinical Trial of CARBAVANCE®,2016-06-27 11:31:03 +0000,http://www.publicnow.com/view/0ED87441C3C0B992F053B2E5FE002F2DA36B32DF,[at noodls] - CARBAVANCE (meropenem-vaborbactam) met both FDA and EMA pre-specified primary endpoints in patients with complicated urinary tract infections (cUTI) CARBAVANCE demonstrated statistical superiority over ...
MDCO,MDCO:UW,BBG000DX6TV8,Add Up The Pieces: JKJ Could Be Worth $152,2016-06-23 12:59:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OSF7wipo3SY/add-up-the-pieces-jkj-could-be-worth-152-cm639440,"Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel , we have compared the trading price of each holding against the average analyst 12 month forward target price, and computed the weighted average"
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company Completes Divestiture of its Non-Core Cardiovascular Assets to Chiesi,2016-06-21 22:39:02 +0000,http://www.publicnow.com/view/EC9B1EB848F2F9B8A11505FA0143307AFC260498,"[at noodls] - PARSIPPANY, N.J.--(BUSINESS WIRE)--Jun. 21, 2016-- The Medicines Company (NASDAQ:MDCO) today announced the completion of the previously-disclosed divestiture of its non-core cardiovascular assets, Cleviprex® ..."
MDCO,MDCO:UW,BBG000DX6TV8,First Week of August 19th Options Trading For Medicines (MDCO),2016-06-21 16:03:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/f9AoW4BMUVc/first-week-of-august-19th-options-trading-for-medicines-mdco-cm638464,"Investors in Medicines Co (Symbol MDCO) saw new options become available this week, for the August 19th expiration. At Stock Options Channel , our YieldBoost formula has looked up and down the MDCO options chain for the new August"
MDCO,MDCO:UW,BBG000DX6TV8,"CHMA Trims Workforce, INFI's DYNAMO Disappoints, Marathon Joins DMD Race",2016-06-14 22:46:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fJX5lmZQdB0/chma-trims-workforce-infis-dynamo-disappoints-marathon-joins-dmd-race-20160614-01108,"CHMA Trims Workforce, INFI's DYNAMO Disappoints, Marathon Joins DMD Race"
MDCO,MDCO:UW,BBG000DX6TV8,"CHMA Trims Workforce, INFI''s DYNAMO Disappoints, Marathon Joins DMD Race",2016-06-14 22:46:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/miHHQW-M88g/chma-trims-workforce-infis-dynamo-disappoints-marathon-joins-dmd-race-20160614-01112,"CHMA Trims Workforce, INFI''s DYNAMO Disappoints, Marathon Joins DMD Race"
MDCO,MDCO:UW,BBG000DX6TV8,MDCO Makes Notable Cross Below Critical Moving Average,2016-06-14 18:08:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aPCwJp-KKn0/mdco-makes-notable-cross-below-critical-moving-average-cm635348,"In trading on Tuesday, shares of Medicines Co (Symbol MDCO) crossed below their 200 day moving average of $35.96, changing hands as low as $35.61 per share. Medicines Co shares are currently trading off about 1.7% on the day."
MDCO,MDCO:UW,BBG000DX6TV8,"The Medicines Company Announces Initiation of Phase II Study for its Investigational Anesthetic, ABP-700",2016-06-14 11:39:02 +0000,http://www.publicnow.com/view/6CE64165473E210D06CC7D55B8454DFA37BDD9C1,"[at noodls] - Phase II study to include 75 patients undergoing elective colonoscopies Results anticipated later in 2016 Rapid phase transition following reports of Phase I clinical pharmacology, dosing and safety data ..."
MDCO,MDCO:UW,BBG000DX6TV8,"Health Care Sector Update for 06/07/2016: MDCO,LDRH,ZBH,VRX",2016-06-07 20:10:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R7fLB3w0L8E/health-care-sector-update-for-06072016-mdcoldrhzbhvrx-cm631864,"Top Health Care Stocks JNJ +0.09% PFE +0.07% MRK 0.43% ABT 0.28% AMGN 0.78% Health care stocks were mixed this afternoon, with the NYSE Health Care Index rising around 0.1% while shares of health care companies in the S&P"
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company Prices $350 Million of Convertible Notes,2016-06-07 03:18:04 +0000,http://www.publicnow.com/view/9A5F822C2895AAF8BAC627C1223089261976B293,"[at noodls] - PARSIPPANY, N.J.--(BUSINESS WIRE)--Jun. 6, 2016-- The Medicines Company (NASDAQ:MDCO) (the 'Company') today announced that it has priced its private offering of $350 million in aggregate principal amount ..."
MDCO,MDCO:UW,BBG000DX6TV8,"AKAO Abuzz, AAAP Gets FDA Blessing, CORT Under Close Watch, Big Day For MBRX",2016-06-02 20:17:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sXElo_ncTGY/akao-abuzz-aaap-gets-fda-blessing-cort-under-close-watch-big-day-for-mbrx-20160602-01260,"AKAO Abuzz, AAAP Gets FDA Blessing, CORT Under Close Watch, Big Day For MBRX"
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company Completes Patient Enrollment for ORION-1 Study of PCSK9si,2016-06-02 11:15:04 +0000,http://www.publicnow.com/view/24D3BE0408F1E4E9ED7D72B479D8532F7D3AD83D,[at noodls] - Phase II study enrolled ahead of schedule Randomized 501 patients with high cardiovascular risk and high LDL-C ('bad cholesterol') despite current treatment Aim to demonstrate LDL-C lowering for six months ...
MDCO,MDCO:UW,BBG000DX6TV8,New incentives needed to develop antibiotics to fight superbugs,2016-05-29 11:00:01 +0000,http://uk.finance.yahoo.com/news/incentives-needed-develop-antibiotics-fight-110001916.html,New incentives needed to develop antibiotics to fight superbugs
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Co. Carbavance TANGO 1 Study Enrolled,2016-05-27 21:06:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/A-oqXFUy7NQ/the-medicines-co-carbavance-tango-1-study-enrolled-cm627741,"The Medicines CompanyMDCO announced that it has completed patient enrollment ahead of schedule in the phase III TANGO 1 study on one of its pipeline candidates, Carbavance (meropenem vaborbactam), for the treatment of complicated urinary tract infections (cUTI). TANGO"
MDCO,MDCO:UW,BBG000DX6TV8,"TTNP On A High, Double Blessing For NERV, AVIR In Trouble, SAGE Awaits Data",2016-05-26 23:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OGx5Yl3_GpE/ttnp-on-a-high-double-blessing-for-nerv-avir-in-trouble-sage-awaits-data-20160526-01241,"TTNP On A High, Double Blessing For NERV, AVIR In Trouble, SAGE Awaits Data"
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company Announces Completion of Patient Enrollment in Phase 3 TANGO 1 Study of CARBAVANCE® (meropenem-vaborbactam) for Treatment of Complicated Urinary Tract Infections (cUTI),2016-05-26 20:57:03 +0000,http://www.publicnow.com/view/DCB7B50BB878E7DCE86D93E2E91BB5E821825098,"[at noodls] - Patient enrollment completed ahead of schedule PARSIPPANY, N.J.--(BUSINESS WIRE)--May 26, 2016-- The Medicines Company (NASDAQ:MDCO) has announced the completion of patient enrollment in the Phase 3 TANGO ..."
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company to Present at Two Upcoming Investor Conferences,2016-05-25 22:16:05 +0000,http://www.publicnow.com/view/F9B50EFA3D6E6ADD56A068199171421CCE29DFF3,"[at noodls] - PARSIPPANY, N.J.--(BUSINESS WIRE)--May 25, 2016-- The Medicines Company (NASDAQ:MDCO) today announced that the company is scheduled to make presentations at the following June investor conferences: Jefferies ..."
MDCO,MDCO:UW,BBG000DX6TV8,"Notable Friday Option Activity: SEAS, QSII, MDCO",2016-05-20 20:49:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aFPA6F7Iu_0/notable-friday-option-activity-seas-qsii-mdco-cm624372,"Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in SeaWorld Entertainment Inc. (Symbol SEAS), where a total of 18,959 contracts have traded so far, representing approximately 1.9 million underlying shares. That"
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company Appoints Tony Kingsley as President and Chief Operating Officer,2016-05-16 11:32:09 +0000,http://www.publicnow.com/view/D5AD31309FBD06E7D3F75B44D58E038B06F15B0F,"[at noodls] - PARSIPPANY, N.J.--(BUSINESS WIRE)--May 16, 2016-- The Medicines Company (NASDAQ:MDCO) has announced the appointment of Tony Kingsley as President and Chief Operating Officer. Mr. Kingsley will help oversee ..."
MDCO,MDCO:UW,BBG000DX6TV8,Deals of the day- Mergers and acquisitions,2016-05-09 20:05:04 +0000,http://sg.finance.yahoo.com/news/deals-day-mergers-acquisitions-141726797.html,Deals of the day- Mergers and acquisitions
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company Agrees to Divest Non-Core Cardiovascular Assets to Chiesi Farmaceutici S.p.A.,2016-05-09 11:36:03 +0000,http://www.publicnow.com/view/424DE999A479CB4F392EFD083244D9D2F2B817A2,"[at noodls] - Chiesi will acquire Cleviprex® (clevidipine) injectable emulsion, Kengreal® (cangrelor) and rights to Argatroban for Injection Total consideration of up to $792 million and anticipated reduction in annual ..."
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company Reports First-Quarter 2016 Business and Financial Results,2016-05-09 11:36:03 +0000,http://www.publicnow.com/view/A1B89A0C47320B215C5946D62826B61F0071B0F6,[at noodls] - Four potential blockbuster R&D programs advancing toward key data disclosures in 2016 The announced divestiture of non-core cardiovascular assets to Chiesi Farmaceutici S.p.A. will sharpen strategic focus ...
MDCO,MDCO:UW,BBG000DX6TV8,Medicines Co. reports 1Q loss,2016-05-09 11:35:34 +0000,http://sg.finance.yahoo.com/news/medicines-co-reports-1q-loss-113534955.html,Medicines Co. reports 1Q loss
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company to Present at Bank of America Merrill Lynch 2016 Health Care Conference,2016-05-02 12:50:04 +0000,http://www.publicnow.com/view/DCA51511DBBC0AEAA3650A55B3E1F3A9503B4D84,"[at noodls] - PARSIPPANY, N.J.--(BUSINESS WIRE)--May 2, 2016-- The Medicines Company (NASDAQ:MDCO) is scheduled to present at the Bank of America Merrill Lynch 2016 Health Care Conference in Las Vegas, NV on Tuesday, ..."
MDCO,MDCO:UW,BBG000DX6TV8,"The Medicines Company to Announce First Quarter Financial Results on May 9, 2016",2016-04-26 13:31:14 +0000,http://www.publicnow.com/view/1F972D3109A0F43936F56F0A3634605387089431,"[at noodls] - PARSIPPANY, N.J.--(BUSINESS WIRE)--Apr. 26, 2016-- The Medicines Company (NASDAQ:MDCO) has scheduled its quarterly conference call forMay 9 at 8:30 a.m. Eastern Time to discuss first quarter financial ..."
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company Announces Participation at 2016 American College of Cardiology (ACC) Scientific Sessions in Chicago,2016-03-28 21:37:04 +0000,http://www.publicnow.com/view/FC29653995FA474D5E9938D3455ED8D9A09EC306,"[at noodls] - - Researchers to present new analyses highlighting the potential clinical and economic value of KENGREAL® in high risk PCI PARSIPPANY, N.J.--(BUSINESS WIRE)--Mar. 28, 2016-- The Medicines Company (NASDAQ:MDCO) ..."
MDCO,MDCO:UW,BBG000DX6TV8,Medicines Co. reports 4Q loss,2016-02-17 12:27:30 +0000,http://sg.finance.yahoo.com/news/medicines-co-reports-4q-loss-122730882.html,Medicines Co. reports 4Q loss
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company Advances Clinical Development of Investigational First-in-Class PCSK9 Synthesis Inhibitor for Atherosclerotic Cardiovascular Disease (ASCVD),2016-01-11 13:08:04 +0000,http://www.noodls.com/view/59C37936E2EC4B0F49F8CF1FAECED1FE0D3B8707,[at noodls] - Initiates sites and begins enrolling patients in dose-finding Phase 2 study Study will evaluate effectiveness of ALN-PCSsc on LDL-C levels with quarterly and bi-annual dosing regimens to determine dose ...
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company to Participate in J.P. Morgan 34th Annual Healthcare Conference,2016-01-04 15:28:14 +0000,http://www.noodls.com/view/442CF7C4F1332404D5D2A936EF165EFDF60309CC,"[at noodls] - --(BUSINESS WIRE)--Jan. 4, 2016-- The (NASDAQ:MDCO) is scheduled to present at the J.P. Morgan 34 Annual Healthcare Conference in on at / . The session will be webcast with a link available at The Medicines ..."
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company Agrees to Divest its Hemostasis Portfolio to Mallinckrodt plc,2015-12-18 14:05:45 +0000,http://www.noodls.com/view/F921B7D7A63E3E984C1EBF5A2BAF3F68A24A1F9D,"[at noodls] - Portfolio includes Raplixa™(fibrin sealant), Preveleak™, and Recothrom® Thrombin topical (Recombinant) Total potential consideration of up to --(BUSINESS WIRE)--Dec. 18, 2015-- The (NASDAQ:MDCO) today ..."
MDCO,MDCO:UW,BBG000DX6TV8,"The Medicines Company Announces Investigational Lipid Modulating Agent, MDCO-216, Phase 1 Data Published in European Heart Journal- Cardiovascular Pharmacotherapy",2015-12-15 01:14:10 +0000,http://www.noodls.com/view/34E80772A5F3935DD14A18AA38C1B31CD469BF3B,"[at noodls] - MDCO-216 demonstrates pronounced effect on ABCA1-mediated cholesterol efflux, a key marker of the mechanism by which MDCO-216 has the potential to reduce atherosclerotic plaque burden Agent induces phenotype ..."
MDCO,MDCO:UW,BBG000DX6TV8,Glenn Sblendorio To Retire as President and Chief Financial Officer from The Medicines Company,2015-12-09 22:33:27 +0000,http://www.noodls.com/view/B7E25A1A8C0AAE2D31F2F665A7301435549786B2,"[at noodls] - PARSIPPANY, N.J.--(BUSINESS WIRE)--Dec. 9, 2015-- The Medicines Company (NASDAQ:MDCO) announced today that Glenn Sblendorio, President and Chief Financial Officer, will retire from the company effective ..."
MDCO,MDCO:UW,BBG000DX6TV8,Medicines Co. reports 3Q loss,2015-11-03 13:28:16 +0000,http://sg.finance.yahoo.com/news/medicines-co-reports-3q-loss-132816196.html,Medicines Co. reports 3Q loss
MDCO,MDCO:UW,BBG000DX6TV8,Analysis from CHAMPION PHOENIX Trial Highlight the Efficacy of Cangrelor among Patients undergoing PCI via the Radial Approach,2015-09-01 11:00:00 +0000,http://uk.finance.yahoo.com/news/analysis-champion-phoenix-trial-highlight-110000669.html,Analysis from CHAMPION PHOENIX Trial Highlight the Efficacy of Cangrelor among Patients undergoing PCI via the Radial Approach
MDCO,MDCO:UW,BBG000DX6TV8,Medicines shares surge on upbeat cholesterol drug study,2015-08-31 11:49:45 +0000,http://sg.finance.yahoo.com/news/medicines-shares-surge-upbeat-cholesterol-114945443.html,Medicines shares surge on upbeat cholesterol drug study
MDCO,MDCO:UW,BBG000DX6TV8,"Alnylam, Medicines cholesterol drug lasts months after one shot",2015-08-30 09:11:12 +0000,http://in.finance.yahoo.com/news/alnylam-medicines-cholesterol-drug-lasts-091112224.html,"Alnylam, Medicines cholesterol drug lasts months after one shot"
MDCO,MDCO:UW,BBG000DX6TV8,"Alnylam, Medicines cholesterol drug lasts months after one shot",2015-08-30 09:11:12 +0000,http://sg.finance.yahoo.com/news/alnylam-medicines-cholesterol-drug-lasts-091112216.html,"Alnylam, Medicines cholesterol drug lasts months after one shot"
MDCO,MDCO:UW,BBG000DX6TV8,ALN-PCSsc Achieves Quarterly and Potentially Bi-Annual Subcutaneous Dose Regimen Profile for Effective LDL-C Lowering in Phase 1 Clinical Study,2015-08-30 07:30:00 +0000,http://uk.finance.yahoo.com/news/aln-pcssc-achieves-quarterly-potentially-073000960.html,ALN-PCSsc Achieves Quarterly and Potentially Bi-Annual Subcutaneous Dose Regimen Profile for Effective LDL-C Lowering in Phase 1 Clinical Study
MDCO,MDCO:UW,BBG000DX6TV8,The Medicines Company Announces Participation at 2015 European Society of Cardiology (ESC) Congress in London,2015-08-24 11:00:00 +0000,http://uk.finance.yahoo.com/news/medicines-company-announces-participation-2015-110000787.html,The Medicines Company Announces Participation at 2015 European Society of Cardiology (ESC) Congress in London
MDCO,MDCO:UW,BBG000DX6TV8,Medicines Co. reports 2Q loss,2015-07-29 13:01:04 +0000,http://sg.finance.yahoo.com/news/medicines-co-reports-2q-loss-130104889.html,Medicines Co. reports 2Q loss
MDCO,MDCO:UW,BBG000DX6TV8,Medicines Co. misses 1Q revenue forecasts,2015-05-05 11:33:56 +0000,http://sg.finance.yahoo.com/news/medicines-co-misses-1q-revenue-113356387.html,Medicines Co. misses 1Q revenue forecasts
MDCO,MDCO:UW,BBG000DX6TV8,"BUZZ-U.S. STOCKS ON THE MOVE-LinkedIn, Tesla, Lloyds, CVS Health",2015-05-01 12:11:11 +0000,http://uk.finance.yahoo.com/news/buzz-u-stocks-move-linkedin-121111233.html,"BUZZ-U.S. STOCKS ON THE MOVE-LinkedIn, Tesla, Lloyds, CVS Health"
MDCO,MDCO:UW,BBG000DX6TV8,Medicines Co. slumps as company forecasts big sales decline,2015-04-09 22:34:17 +0000,http://sg.finance.yahoo.com/news/medicines-co-slumps-company-forecasts-223417605.html,Medicines Co. slumps as company forecasts big sales decline
MDCO,MDCO:UW,BBG000DX6TV8,US STOCKS-Wall St ends up on energy rebound; early earnings weak,2015-04-09 20:56:50 +0000,http://uk.finance.yahoo.com/news/us-stocks-wall-st-ends-205650253.html,US STOCKS-Wall St ends up on energy rebound; early earnings weak
MDCO,MDCO:UW,BBG000DX6TV8,Medicines Co. beats 3Q earnings expectations,2014-10-22 11:16:18 +0000,http://sg.finance.yahoo.com/news/medicines-co-beats-3q-earnings-111618359--finance.html,Medicines Co. beats 3Q earnings expectations
